BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1866] [Cited by in F6Publishing: 2001] [Article Influence: 124.4] [Reference Citation Analysis]
Number Citing Articles
1 Yin KL, Li M, Song PP, Duan YX, Ye WT, Tang W, Kokudo N, Gao Q, Liao R. Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases. J Clin Transl Hepatol 2023;11:441-51. [PMID: 36643031 DOI: 10.14218/JCTH.2022.00326] [Reference Citation Analysis]
2 You L, Nepovimova E, Valko M, Wu Q, Kuca K. Mycotoxins and cellular senescence: the impact of oxidative stress, hypoxia, and immunosuppression. Arch Toxicol 2023;97:393-404. [PMID: 36434400 DOI: 10.1007/s00204-022-03423-x] [Reference Citation Analysis]
3 Rashidi M, Matour E, Nasab HB, Cheraghzadeh M, Shakerian E. Isorhamnetin exerts antifibrosis effects by attenuating PDGF-BB--induced HSC-T6 cells activation via suppressing PI3K-AKT Signaling Pathway, a new remedy for liver fibrosis.. [DOI: 10.21203/rs.3.rs-1910539/v2] [Reference Citation Analysis]
4 Wu X, Fan X, Miyata T, Kim A, Cajigas-Du Ross CK, Ray S, Huang E, Taiwo M, Arya R, Wu J, Nagy LE. Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease. Annu Rev Pathol 2023;18:411-38. [PMID: 36270295 DOI: 10.1146/annurev-pathmechdis-031521-030435] [Reference Citation Analysis]
5 Zhang A, Qian F, Li Y, Li B, Yang F, Hu C, Sun W, Huang Y. Research progress of metformin in the treatment of liver fibrosis. Int Immunopharmacol 2023;116:109738. [PMID: 36696857 DOI: 10.1016/j.intimp.2023.109738] [Reference Citation Analysis]
6 Nokkeaw A, Thamjamrassri P, Tangkijvanich P, Ariyachet C. Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis. Cells 2023;12:378. [DOI: 10.3390/cells12030378] [Reference Citation Analysis]
7 Tian G, Ren T. Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases. Eur J Cell Biol 2023;102:151288. [PMID: 36696810 DOI: 10.1016/j.ejcb.2023.151288] [Reference Citation Analysis]
8 Ribatti D. Liver angiocrine factors. Tissue Cell 2023;81:102027. [PMID: 36657255 DOI: 10.1016/j.tice.2023.102027] [Reference Citation Analysis]
9 Xiang L, Wang X, Shao Y, Jiao Q, Cheng J, Zheng X, Zhou S, Chen Y. Folate Decoration Supports the Targeting of Camptothecin Micelles against Activated Hepatic Stellate Cells and the Suppression of Fibrogenesis. ACS Appl Mater Interfaces 2023;15:2030-42. [PMID: 36571106 DOI: 10.1021/acsami.2c16616] [Reference Citation Analysis]
10 Collins A, Scott R, Wilson CL, Abbate G, Ecclestone G, Biddles D, Oakley F, Mann J, Mann DA, Kenneth NS. UCHL1-dependent control of Hypoxia-Inducible Factor Transcriptional Activity in Liver Disease.. [DOI: 10.1101/2023.01.08.523142] [Reference Citation Analysis]
11 Wang D, Xu H, Fan L, Ruan W, Song Q, Diao H, He R, Jin Y. Hyperphosphorylation of EGFR/ERK signaling facilitates long-term arsenite-induced hepatocytes epithelial-mesenchymal transition and liver fibrosis in sprague-dawley rats. Ecotoxicol Environ Saf 2023;249:114386. [PMID: 36508792 DOI: 10.1016/j.ecoenv.2022.114386] [Reference Citation Analysis]
12 Li TT, Su XW, Chen LL, Zhang WN, Zhang JP, Wang Y, Xu WH. Roxarsone inhibits hepatic stellate cell activation and ameliorates liver fibrosis by blocking TGF-β1/Smad signaling pathway. Int Immunopharmacol 2023;114:109527. [PMID: 36700762 DOI: 10.1016/j.intimp.2022.109527] [Reference Citation Analysis]
13 Fan J, Tong G, Chen X, Li S, Yu Y, Zhu S, Zhu K, Hu Z, Dong Y, Chen R, Zhu J, Gong W, Hu Z, Zhou B, Chen Y, Jin L, Cong W. CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the Hedgehog pathway. Br J Pharmacol 2023;180:44-61. [PMID: 36070072 DOI: 10.1111/bph.15945] [Reference Citation Analysis]
14 Zhu C, Huai Q, Zhang X, Dai H, Li X, Wang H. Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. Int J Biol Sci 2023;19:311-30. [PMID: 36594091 DOI: 10.7150/ijbs.78525] [Reference Citation Analysis]
15 Kang GG, Trevaskis NL, Murphy AJ, Febbraio MA. Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH. iScience 2023;26:105905. [PMID: 36691622 DOI: 10.1016/j.isci.2022.105905] [Reference Citation Analysis]
16 Hao Y, Song K, Tan X, Ren L, Guo X, Zhou C, Li H, Wen J, Meng Y, Lin M, Zhang Y, Huang H, Wang L, Zheng W. Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis. ACS Nano 2022;16:20739-57. [PMID: 36454190 DOI: 10.1021/acsnano.2c07796] [Reference Citation Analysis]
17 Kim CW, Yoon Y, Kim MY, Baik SK, Ryu H, Park IH, Eom YW. 12-O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP. Cells 2022;12. [PMID: 36611885 DOI: 10.3390/cells12010091] [Reference Citation Analysis]
18 Xu Y, Liu F, He D, Han L, Zheng X, Hu M, Chen P. Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10. Immunobiology 2022;228:152315. [PMID: 36608595 DOI: 10.1016/j.imbio.2022.152315] [Reference Citation Analysis]
19 Gutiérrez-Cuevas J, Lucano-Landeros S, López-Cifuentes D, Santos A, Armendariz-Borunda J. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. Cancers (Basel) 2022;15. [PMID: 36612019 DOI: 10.3390/cancers15010023] [Reference Citation Analysis]
20 Ali Choaib, Elio Issa, Francesca El Choueiry, Jade Nasser Eldin, Khodor Shbaklo, Maryline Alhajj, Ramy Touma Sawaya, Ghaith Assi, Moni Nader, Rajaa Chatila, Wissam H. Faour. SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease. Inflamm Res 2022. [PMID: 36539655 DOI: 10.1007/s00011-022-01683-y] [Reference Citation Analysis]
21 Mak KM, Wu C, Cheng CP. Lipid droplets, the Holy Grail of hepatic stellate cells: In health and hepatic fibrosis. The Anatomical Record 2022. [DOI: 10.1002/ar.25138] [Reference Citation Analysis]
22 Jiang Z, Ma X, Luan X, Liuyang Z, Hong Y, Dai Y, Dong Q, Wang G. BMI-1 activates hepatic stellate cells to promote EMT of colorectal cancer cells.. [DOI: 10.21203/rs.3.rs-2247681/v1] [Reference Citation Analysis]
23 Dong H, Zhao L, Sun H, Shang M, Lv G, Yu X, Hu B, Huang Y. Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models. Parasit Vectors 2022;15:460. [PMID: 36510325 DOI: 10.1186/s13071-022-05548-5] [Reference Citation Analysis]
24 Jeong M, See J, De La Torre C, Cerwenka A, Stojanovic A. Vitamin A-treated NK cells reduce IFN-γ production and support regulatory T cell differentiation.. [DOI: 10.1101/2022.12.05.519129] [Reference Citation Analysis]
25 Petersen OH. Watching Living Cells in Action in the Exocrine Pancreas: The Palade Prize Lecture. Function (Oxf) 2023;4:zqac061. [PMID: 36606242 DOI: 10.1093/function/zqac061] [Reference Citation Analysis]
26 Mohammad Omar J, Hai Y, Jin S. Hypoxia-induced factor and its role in liver fibrosis. PeerJ 2022;10:e14299. [PMID: 36523459 DOI: 10.7717/peerj.14299] [Reference Citation Analysis]
27 Pibiri M, Simbula G. Role of the Hippo pathway in liver regeneration and repair: recent advances. Inflamm Regen 2022;42:59. [PMID: 36471376 DOI: 10.1186/s41232-022-00235-5] [Reference Citation Analysis]
28 Chen X, Niu X, Liu Y, Zheng R, Yang L, Lu J, Yin S, Wei Y, Pan J, Sayed A, Ma X, Liu M, Jing F, Liu M, Hu J, Wang L, Li D. Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration. J Genet Genomics 2022;49:1114-26. [PMID: 35691554 DOI: 10.1016/j.jgg.2022.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mitten EK, Baffy G. Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 2022;77:1642-56. [PMID: 36063966 DOI: 10.1016/j.jhep.2022.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Han H, Jin W, Li X. Mesenchymal stem cells-based therapy in liver diseases. Mol Biomed 2022;3:23. [DOI: 10.1186/s43556-022-00088-x] [Reference Citation Analysis]
31 Hsiao SK, Liang CW, Chang TL, Sung YC, Chen YT, Chen Y, Wang J. An in vitro fibrotic liver lobule model through sequential cell-seeding of HSCs and HepG2 on 3D-printed poly(glycerol sebacate) acrylate scaffolds. J Mater Chem B 2022;10:9590-8. [PMID: 36106522 DOI: 10.1039/d1tb02686k] [Reference Citation Analysis]
32 Lee SY, Kim S, Choi I, Song Y, Kim N, Ryu HC, Lim JW, Kang HJ, Kim J, Seo HR. Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH. Cell Death Dis 2022;13:1011. [PMID: 36446766 DOI: 10.1038/s41419-022-05452-x] [Reference Citation Analysis]
33 Peng X, Yang H, Tao L, Xiao J, Zeng Y, Shen Y, Yu X, Qin J. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway.. [DOI: 10.21203/rs.3.rs-2251158/v1] [Reference Citation Analysis]
34 Cho SS, Yang JH, Lee JH, Baek JS, Ku SK, Cho IJ, Kim KM, Ki SH. Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis. Free Radic Biol Med 2022;193:620-37. [PMID: 36370962 DOI: 10.1016/j.freeradbiomed.2022.11.011] [Reference Citation Analysis]
35 Begli NH, Freund C, Weiss K, Gotthardt D, Wannhoff A. Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis.. [DOI: 10.21203/rs.3.rs-1344377/v2] [Reference Citation Analysis]
36 Li B, Zhou J, Luo Y, Tao K, Zhang L, Zhao Y, Lin Y, Zeng X, Yu H. Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1050093] [Reference Citation Analysis]
37 Zhao J, Li R, Li J, Chen Z, Lin Z, Zhang B, Deng L, Chen G, Wang Y. CAFs-derived SCUBE1 promotes malignancy and stemness through the Shh/Gli1 pathway in hepatocellular carcinoma. J Transl Med 2022;20:520. [DOI: 10.1186/s12967-022-03689-w] [Reference Citation Analysis]
38 Perez‐gutierrez L, Li P, Ferrara N. Endothelial cell diversity: the many facets of the crystal. The FEBS Journal 2022. [DOI: 10.1111/febs.16660] [Reference Citation Analysis]
39 Zhang H, Zhou P, Xing W, Chen L, Zhou Y, Yang H, Fu K, Liu Z. GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation. Cell Mol Gastroenterol Hepatol 2023;15:355-72. [PMID: 36397300 DOI: 10.1016/j.jcmgh.2022.10.015] [Reference Citation Analysis]
40 Feng H, Zhuo Y, Zhang X, Li Y, Li Y, Duan X, Shi J, Xu C, Gao Y, Yu Z. Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy. J Hepatocell Carcinoma 2022;9:1109-25. [PMID: 36320666 DOI: 10.2147/JHC.S381764] [Reference Citation Analysis]
41 Mohamed AE, Mahmoud AM, Mohamed WR, Mohamed T. Femtosecond laser attenuates oxidative stress, inflammation, and liver fibrosis in rats: Possible role of PPARγ and Nrf2/HO-1 signaling. Life Sci 2022;307:120877. [PMID: 35963297 DOI: 10.1016/j.lfs.2022.120877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Garbuzenko DV. Current strategies for targeted therapy of liver fibrosis. Bûll sib med 2022;21:154-165. [DOI: 10.20538/1682-0363-2022-3-154-165] [Reference Citation Analysis]
43 Zheng M, Okawa S, Bravo M, Chen F, Martínez-Chantar ML, Del Sol A. ChemPert: mapping between chemical perturbation and transcriptional response for non-cancer cells. Nucleic Acids Res 2023;51:D877-89. [PMID: 36200827 DOI: 10.1093/nar/gkac862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 de Hoyos‐vega JM, Hong HJ, Loutherback K, Stybayeva G, Revzin A. A Microfluidic Device for Long‐Term Maintenance of Organotypic Liver Cultures. Adv Materials Technologies. [DOI: 10.1002/admt.202201121] [Reference Citation Analysis]
45 Floreani A, Gabbia D, De Martin S. Obeticholic Acid for Primary Biliary Cholangitis. Biomedicines 2022;10:2464. [PMID: 36289726 DOI: 10.3390/biomedicines10102464] [Reference Citation Analysis]
46 Lai X, Li C, Xiang C, Pan Z, Zhang K, Wang L, Xie B, Cao J, Shi J, Deng J, Lu S, Deng H, Zhuang H, Li T, Shi Y, Xiang K. Generation of functionally competent hepatic stellate cells from human stem cells to model liver fibrosis in vitro. Stem Cell Reports 2022. [DOI: 10.1016/j.stemcr.2022.09.010] [Reference Citation Analysis]
47 Chen T, Shi Z, Zhao Y, Meng X, Zhao S, Zheng L, Han X, Hu Z, Yao Q, Lin H, Du X, Zhang K, Han T, Hong W. LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Med 2022;20:335. [PMID: 36171606 DOI: 10.1186/s12916-022-02523-w] [Reference Citation Analysis]
48 Li S, Hu X, Yu S, Yi P, Chen R, Huang Z, Huang Y, Huang Y, Zhou R, Fan X. Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG/miR-506-3p/TGFB1 axis. Cancer Sci 2022. [PMID: 36169092 DOI: 10.1111/cas.15605] [Reference Citation Analysis]
49 Song J, Liu L, Wang Z, Xie D, Azami NLB, Lu L, Huang Y, Zhang Q, Sun M. CCL20 and CD8A as diagnostic biomarkers for HBV infection-induced hepatic fibrosis development, including immune infiltration in HBV-LF.. [DOI: 10.21203/rs.3.rs-2042069/v1] [Reference Citation Analysis]
50 Gong F, Qu R, Li Y, Lv Y, Dai J. Astragalus Mongholicus: A review of its anti-fibrosis properties. Front Pharmacol 2022;13:976561. [DOI: 10.3389/fphar.2022.976561] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hung CT, Tsai YW, Wu YS, Yeh CF, Yang KC. The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications. J Biomed Sci 2022;29:63. [PMID: 36050716 DOI: 10.1186/s12929-022-00850-x] [Reference Citation Analysis]
52 Tang M, Guo C, Sun M, Zhou H, Peng X, Dai J, Ding Q, Wang Y, Yang C. Effective delivery of osteopontin small interference RNA using exosomes suppresses liver fibrosis via TGF-β1 signaling. Front Pharmacol 2022;13:882243. [DOI: 10.3389/fphar.2022.882243] [Reference Citation Analysis]
53 Hung CT, Su TH, Chen YT, Wu YF, Chen YT, Lin SJ, Lin SL, Yang KC. Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling. Gut 2022;71:1876-91. [PMID: 34933915 DOI: 10.1136/gutjnl-2021-325065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
54 Elchaninov A, Vishnyakova P, Menyailo E, Sukhikh G, Fatkhudinov T. An Eye on Kupffer Cells: Development, Phenotype and the Macrophage Niche. IJMS 2022;23:9868. [DOI: 10.3390/ijms23179868] [Reference Citation Analysis]
55 Kartasheva-ebertz D, Gaston J, Lair-mehiri L, Mottez E, Buivan T, Massault P, Scatton O, Gaujoux S, Vaillant J, Pol S, Lagaye S. IL-17A in Human Liver: Significant Source of Inflammation and Trigger of Liver Fibrosis Initiation. IJMS 2022;23:9773. [DOI: 10.3390/ijms23179773] [Reference Citation Analysis]
56 Kamal MA, Mandour YM, Abd El-aziz MK, Stein U, El Tayebi HM. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges. Molecules 2022;27:5537. [DOI: 10.3390/molecules27175537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Wu Y, Ge X, Wang S, Zhang C, Wada K. Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/4710993] [Reference Citation Analysis]
58 Duan N, Chen H, Pi L, Ali Y, Cao Q. Cis-4-[18F]fluoro-L-proline PET/CT molecular imaging quantifying liver collagenogenesis: No existing fibrotic deposition in experimental advanced-stage alcoholic liver fibrosis. Front Nucl Med 2022;2. [DOI: 10.3389/fnume.2022.952943] [Reference Citation Analysis]
59 Ariyachet C, Chuaypen N, Kaewsapsak P, Chantaravisoot N, Jindatip D, Potikanond S, Tangkijvanich P. MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury. Int J Mol Sci 2022;23:9380. [PMID: 36012644 DOI: 10.3390/ijms23169380] [Reference Citation Analysis]
60 Yue L, Xue T, Su X, Liu Z, Liu H, Tan Z, Gan C, Xie Y, Ye T. Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents. Eur J Med Chem 2022;242:114685. [PMID: 36037790 DOI: 10.1016/j.ejmech.2022.114685] [Reference Citation Analysis]
61 Xi Y, LaCanna R, Ma HY, N'Diaye EN, Gierke S, Caplazi P, Sagolla M, Huang Z, Lucio L, Arlantico A, Jeet S, Brightbill H, Emson C, Wong A, Morshead KB, DePianto DJ, Roose-Girma M, Yu C, Tam L, Jia G, Ramalingam TR, Marsters S, Ashkenazi A, Kim SH, Kelly R, Wu S, Wolters PJ, Feldstein AE, Vander Heiden JA, Ding N. A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis. Cell Metab 2022:S1550-4131(22)00308-4. [PMID: 35987202 DOI: 10.1016/j.cmet.2022.07.009] [Reference Citation Analysis]
62 Shi Q, Wei S, Li ZC, Xu J, Li Y, Guo C, Wu X, Shi C, Di G. Collagen-binding fibroblast growth factor ameliorates liver fibrosis in murine bile duct ligation injury. J Biomater Appl 2022;:8853282221121861. [PMID: 35969638 DOI: 10.1177/08853282221121861] [Reference Citation Analysis]
63 Kitsugi K, Noritake H, Matsumoto M, Hanaoka T, Umemura M, Yamashita M, Takatori S, Ito J, Ohta K, Chida T, Ulmasov B, Neuschwander-Tetri BA, Suda T, Kawata K. Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway. Cell Signal 2022;99:110437. [PMID: 35970425 DOI: 10.1016/j.cellsig.2022.110437] [Reference Citation Analysis]
64 Mahdinloo S, Hemmati S, Valizadeh H, Mahmoudian M, Mahmoudi J, Roshangar L, Sarfraz M, Zakeri-Milani P. Synthesis and preparation of vitamin A coupled butein-loaded solid lipid nanoparticles for liver fibrosis therapy in rats. Int J Pharm 2022;625:122063. [PMID: 35964827 DOI: 10.1016/j.ijpharm.2022.122063] [Reference Citation Analysis]
65 Van Campenhout R, Leroy K, Cooreman A, Tabernilla A, Cogliati B, Kadam P, Vinken M. Connexin-Based Channels in the Liver. Compr Physiol 2022;12:1-17. [PMID: 35950654 DOI: 10.1002/cphy.c220007] [Reference Citation Analysis]
66 Šrajer Gajdošik M, Kovač Peić A, Begić M, Grbčić P, Brilliant KE, Hixson DC, Josić D. Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen. IJMS 2022;23:8870. [DOI: 10.3390/ijms23168870] [Reference Citation Analysis]
67 Shu W, Yang M, Yang J, Lin S, Wei X, Xu X. Cellular crosstalk during liver regeneration: unity in diversity. Cell Commun Signal 2022;20:117. [PMID: 35941604 DOI: 10.1186/s12964-022-00918-z] [Reference Citation Analysis]
68 Kim KH, Cheng N, Lau LF. Cellular communication network factor 1-stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis. Hepatol Commun 2022. [PMID: 35929736 DOI: 10.1002/hep4.2057] [Reference Citation Analysis]
69 Jiang N, Zhang J, Ping J, Xu L. Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway. Front Pharmacol 2022;13:938856. [PMID: 35991894 DOI: 10.3389/fphar.2022.938856] [Reference Citation Analysis]
70 St Rose K, Yan J, Xu F, Williams J, Dweck V, Saxena D, Schwabe RF, Caviglia JM. Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3. Hepatol Commun 2022;6:2676-88. [PMID: 35923109 DOI: 10.1002/hep4.2035] [Reference Citation Analysis]
71 Han B, Liu Q, Su X, Zhou L, Zhang B, Kang H, Ning J, Li C, Zhao B, Niu Y, Chen W, Chen L, Zhang R. The role of PP2A /NLRP3 signaling pathway in ambient particulate matter 2.5 induced lung injury. Chemosphere 2022. [DOI: 10.1016/j.chemosphere.2022.135794] [Reference Citation Analysis]
72 Ormseth B, Onuma A, Zhang H, Tsung A. The Hepatic Pre-Metastatic Niche. Cancers 2022;14:3731. [DOI: 10.3390/cancers14153731] [Reference Citation Analysis]
73 Beyer D, Hoff J, Sommerfeld O, Zipprich A, Gaßler N, Press AT. The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation. Mol Med 2022;28:84. [PMID: 35907792 DOI: 10.1186/s10020-022-00510-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Peng Y, Yin Q, Yuan M, Chen L, Shen X, Xie W, Liu J. Role of hepatic stellate cells in liver ischemia-reperfusion injury. Front Immunol 2022;13:891868. [DOI: 10.3389/fimmu.2022.891868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Lebeau G, Ah-pine F, Daniel M, Bedoui Y, Vagner D, Frumence E, Gasque P. Perivascular Mesenchymal Stem/Stromal Cells, an Immune Privileged Niche for Viruses? IJMS 2022;23:8038. [DOI: 10.3390/ijms23148038] [Reference Citation Analysis]
76 Qian K, Lei X, Liu G, Fang Y, Xie C, Wu X, Liu Q, Liu G, Cao Z, Zhang J, Kuang T, Yan L, Fu J, Du H, Liu Z, Chu Y, Xu G, Yamamoto H, Mori M, Liang XM, Xu X, Sun Y. Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-β Signaling. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/3100943] [Reference Citation Analysis]
77 Francisco AB, Li J, Farghli AR, Kanke M, Shui B, Munn PR, Grenier JK, Soloway PD, Wang Z, Reid LM, Liu J, Sethupathy P. Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma. Cancer Research Communications 2022;2:663-678. [DOI: 10.1158/2767-9764.crc-21-0177] [Reference Citation Analysis]
78 Wijayasiri P, Astbury S, Kaye P, Oakley F, Alexander GJ, Kendall TJ, Aravinthan AD. Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression. Cells 2022;11:2221. [PMID: 35883664 DOI: 10.3390/cells11142221] [Reference Citation Analysis]
79 Dai Y, Zhao Z, Liu C. Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis. Front Pharmacol 2022;13:942841. [DOI: 10.3389/fphar.2022.942841] [Reference Citation Analysis]
80 Chen X, Zhu S, Chen SY, Wang JN, Sun LJ, Tao SM, Li XF, Li HD, Sun YY, Xu CH, Suo XG, Ji ML, Huang C, Meng XM, Li J. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β. Int Immunopharmacol 2022;110:109034. [PMID: 35834952 DOI: 10.1016/j.intimp.2022.109034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Xu Z, He B, Jiang Y, Zhang M, Tian Y, Zhou N, Zhou Y, Chen M, Tang M, Gao J, Peng F. Igf2bp2 knockdown improves CCl4-induced liver fibrosis and TGF-β-activated mouse hepatic stellate cells by regulating Tgfbr1. Int Immunopharmacol 2022;110:108987. [PMID: 35820364 DOI: 10.1016/j.intimp.2022.108987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Chen G, Harwood JL, Lemieux MJ, Stone SJ, Weselake RJ. Acyl-CoA:diacylglycerol acyltransferase: Properties, physiological roles, metabolic engineering and intentional control. Prog Lipid Res 2022;:101181. [PMID: 35820474 DOI: 10.1016/j.plipres.2022.101181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
83 Wei M, Zhang Y, Zhang H, Huang Z, Miao H, Zhang T, Lu B, Ji L. HMGB1 induced endothelial to mesenchymal transition in liver fibrosis: The key regulation of early growth response factor 1. Biochim Biophys Acta Gen Subj 2022;1866:130202. [PMID: 35820641 DOI: 10.1016/j.bbagen.2022.130202] [Reference Citation Analysis]
84 Yang L, Zhang B. Protective Mechanism of Nostoc sphaeroides Kütz. Polysaccharide on Liver Fibrosis by HFD-Induced Liver Fat Synthesis and Oxidative Stress. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/1745244] [Reference Citation Analysis]
85 Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol 2022;19:432-50. [PMID: 35165436 DOI: 10.1038/s41575-021-00566-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
86 Fondevila MF, Fernandez U, Heras V, Parracho T, Gonzalez-Rellan MJ, Novoa E, Porteiro B, Alonso C, Mayo R, da Silva Lima N, Iglesias C, Filliol AA, Senra A, Delgado TC, Woodhoo A, Herrero L, Serra D, Prevot V, Schwaninger M, López M, Dieguez C, Millet O, Mato JM, Cubero FJ, Varela-Rey M, Iruzubieta P, Crespo J, Martinez-Chantar ML, Schwabe RF, Nogueiras R. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis. J Hepatol 2022;77:15-28. [PMID: 35167910 DOI: 10.1016/j.jhep.2022.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Zhou L, Zhao J, Han M, Liu S, Yuan X, Ma A, Yang S, Zeng Y, Cheng J. Aspartate reduces liver inflammation and fibrosis by suppressing the NLRP3 inflammasome pathway via upregulating NS3TP1 expression.. [DOI: 10.1101/2022.06.27.497857] [Reference Citation Analysis]
88 Mahmood Alabdali AY, Chinnappan S, Abd Razik BM, R M, Ibrahim Khalivulla S, H R. Pharmacological activities of Curcumin: An update. RJPT 2022. [DOI: 10.52711/0974-360x.2022.00469] [Reference Citation Analysis]
89 Bocca C, Protopapa F, Foglia B, Maggiora M, Cannito S, Parola M, Novo E. Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis. Antioxidants 2022;11:1278. [DOI: 10.3390/antiox11071278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Subramanian P, Hampe J, Tacke F, Chavakis T. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD). IJMS 2022;23:6996. [DOI: 10.3390/ijms23136996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 de Hoyos Vega JM, Hong HJ, Loutherback K, Stybayeva G, Revzin A. A MICROFLUIDIC DEVICE FOR LONG-TERM MAINTENANCE OF ORGANOTYPIC LIVER CULTURES.. [DOI: 10.1101/2022.06.18.496606] [Reference Citation Analysis]
92 Zhu S, Chen X, Chen SY, Wang A, Wu S, Wu YY, Cheng M, Xu JJ, Li XF, Huang C, Li J. Hesperetin derivative decreases CCl4 -induced hepatic fibrosis by Ptch1-dependent mechanisms. J Biochem Mol Toxicol 2022;:e23149. [PMID: 35712856 DOI: 10.1002/jbt.23149] [Reference Citation Analysis]
93 Carter JK, Friedman SL. Hepatic Stellate Cell-Immune Interactions in NASH. Front Endocrinol (Lausanne) 2022;13:867940. [PMID: 35757404 DOI: 10.3389/fendo.2022.867940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
94 Miao L, Targher G, Byrne CD, Valenti L, Qi X, Zheng M. Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives. Portal Hypertension & Cirrhosis 2022;1:57-65. [DOI: 10.1002/poh2.8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ben-moshe S, Veg T, Manco R, Dan S, Papinutti D, Lifshitz A, Kolodziejczyk AA, Bahar Halpern K, Elinav E, Itzkovitz S. The spatiotemporal program of zonal liver regeneration following acute injury. Cell Stem Cell 2022;29:973-989.e10. [DOI: 10.1016/j.stem.2022.04.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
96 Galatou E, Mourelatou E, Hatziantoniou S, Vizirianakis IS. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. Antioxidants 2022;11:1060. [DOI: 10.3390/antiox11061060] [Reference Citation Analysis]
97 Shan S, Liu Z, Wang S, Liu Z, Huang Z, Yang Y, Zhang C, Song F. Drp1-mediated mitochondrial fission promotes carbon tetrachloride-induced hepatic fibrogenesis in mice. Toxicology Research 2022. [DOI: 10.1093/toxres/tfac027] [Reference Citation Analysis]
98 Niu L, Geyer PE, Gupta R, Santos A, Meier F, Doll S, Wewer Albrechtsen NJ, Klein S, Ortiz C, Uschner FE, Schierwagen R, Trebicka J, Mann M. Dynamic human liver proteome atlas reveals functional insights into disease pathways. Mol Syst Biol 2022;18:e10947. [PMID: 35579278 DOI: 10.15252/msb.202210947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Han X, Ding C, Ning Y, Shan Q, Niu M, Cai H, Xu P, Cao G. Optimizing Processing Technology of Cornus officinalis: Based on Anti-Fibrotic Activity. Front Nutr 2022;9:807071. [PMID: 35592634 DOI: 10.3389/fnut.2022.807071] [Reference Citation Analysis]
100 Zheng M, Okawa S, Bravo M, Chen F, Martínez-chantar M, del Sol A. ChemPert: mapping between chemical perturbation and transcriptional response for non-cancer cells.. [DOI: 10.1101/2022.04.29.490084] [Reference Citation Analysis]
101 Bae M, Kim M, Lee J. Fucoxanthin Attenuates the Reprogramming of Energy Metabolism during the Activation of Hepatic Stellate Cells. Nutrients 2022;14:1902. [DOI: 10.3390/nu14091902] [Reference Citation Analysis]
102 Li YF, Xie ZF, Song Q, Li JY. Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH. Acta Pharmacol Sin 2022;43:1141-55. [PMID: 35105958 DOI: 10.1038/s41401-022-00864-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
103 Artlett CM. The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis. Biomolecules 2022;12:634. [DOI: 10.3390/biom12050634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Fiorucci S, Zampella A, Ricci P, Distrutti E, Biagioli M. Immunomodulatory functions of FXR. Mol Cell Endocrinol 2022;551:111650. [PMID: 35472625 DOI: 10.1016/j.mce.2022.111650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01569-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
106 Balaphas A, Meyer J, Gameiro C, Frobert A, Giraud M, Egger B, Bühler LH, Gonelle-gispert C. Optimized Isolation and Characterization of C57BL/6 Mouse Hepatic Stellate Cells. Cells 2022;11:1379. [DOI: 10.3390/cells11091379] [Reference Citation Analysis]
107 Umemura A, Kataoka S, Okuda K, Seko Y, Yamaguchi K, Moriguchi M, Okanoue T, Itoh Y. Potential Therapeutic Targets and Promising Agents for Combating NAFLD. Biomedicines 2022;10:901. [DOI: 10.3390/biomedicines10040901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Le Goallec A, Diai S, Collin S, Prost JB, Vincent T, Patel CJ. Using deep learning to predict abdominal age from liver and pancreas magnetic resonance images. Nat Commun 2022;13:1979. [PMID: 35418184 DOI: 10.1038/s41467-022-29525-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Carson JP, Robinson MW, Ramm GA, Gobert GN. Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells. Experimental Parasitology 2022. [DOI: 10.1016/j.exppara.2022.108255] [Reference Citation Analysis]
110 Czaja AJ. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis. Dig Dis Sci 2022;67:1163-86. [PMID: 33835375 DOI: 10.1007/s10620-021-06968-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
111 Liu X, Wang L, Tan S, Chen Z, Wu B, Wu X. Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. Front Pharmacol 2022;13:814871. [PMID: 35308208 DOI: 10.3389/fphar.2022.814871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
112 Ishida S. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project. Front Toxicol 2021;3:657765. [PMID: 35295097 DOI: 10.3389/ftox.2021.657765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Ramani K, Mavila N, Abeynayake A, Tomasi ML, Wang J, Matsuda M, Seki E. Targeting A-Kinase Anchoring Protein 12 Phosphorylation in Hepatic Stellate Cells Regulates Liver Injury and Fibrosis in Mouse Models.. [DOI: 10.1101/2022.03.15.484391] [Reference Citation Analysis]
114 Ji J, Feng M, Huang Y, Niu X. Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro. Bioengineered 2022;13:5091-102. [PMID: 35164657 DOI: 10.1080/21655979.2022.2036902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
115 Kondo R, Deguchi A, Kawata N, Suzuki Y, Yamamura H. Involvement of TREK1 channels in the proliferation of human hepatic stellate LX-2 cells. Journal of Pharmacological Sciences 2022;148:286-94. [DOI: 10.1016/j.jphs.2022.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Wang Z, Zhao Z, Xia Y, Cai Z, Wang C, Shen Y, Liu R, Qin H, Jia J, Yuan G. Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH). J Endocrinol Invest. [DOI: 10.1007/s40618-022-01773-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Li C, Wang M, Fu T, Li Z, Chen Y, He T, Feng D, Wang Z, Fan Q, Chen M, Zhang H, Lin R, Zhao C. Lipidomics Indicates the Hepatotoxicity Effects of EtOAc Extract of Rhizoma Paridis. Front Pharmacol 2022;13:799512. [PMID: 35211012 DOI: 10.3389/fphar.2022.799512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Bae M, Kim M, Lee J. Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells. Nutrients 2022;14:962. [DOI: 10.3390/nu14050962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
119 Zhou L, Li Y, Liang Q, Liu J, Liu Y. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: A review. J Drug Target 2022;:1-22. [PMID: 35179094 DOI: 10.1080/1061186X.2022.2044485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Song YR, Jang MH, Jang B, Bae SJ, Bak SB, Lee SM, Yun U, Lee JH, Park SM, Jung DH, Sa BS, Song JK, Lee EH, Kim KY, Park K, Kim YW, Kim SC. Jageum-Jung, the herbal pharmaceuticals, inhibits the hepatic fibrogenesis as mediated with TGF-β1/smad signaling. Mol Cell Toxicol . [DOI: 10.1007/s13273-021-00196-9] [Reference Citation Analysis]
121 Liu Q, Lv C, Jiang Y, Luo K, Gao Y, Liu J, Zhang X, Mohammad Omar J, Jin S. From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation. PeerJ 2022;10:e12872. [PMID: 35186473 DOI: 10.7717/peerj.12872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Chen R, Li Q, Xu S, Ye C, Tian T, Jiang Q, Shan J, Ruan J. Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment. Cancer Cell Int 2022;22:73. [PMID: 35148789 DOI: 10.1186/s12935-021-02435-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
123 Tang D, Zhang Q, Duan H, Ye X, Liu J, Peng W, Wu C, Angeloni C. Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/9218738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
124 Pereira ENGDS, Araujo BP, Rodrigues KL, Silvares RR, Martins CSM, Flores EEI, Fernandes-Santos C, Daliry A. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress. Nutrients 2022;14:716. [PMID: 35277075 DOI: 10.3390/nu14030716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
125 Mastoridou EM, Goussia AC, Glantzounis GK, Kanavaros P, Charchanti AV. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. Front Physiol 2022;12:801340. [DOI: 10.3389/fphys.2021.801340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
126 Weiz G, Molejon MI, Malvicini M, Sukowati CHC, Tiribelli C, Mazzolini G, Breccia JD. Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma. Liver Int 2022;42:444-57. [PMID: 34800352 DOI: 10.1111/liv.15084] [Reference Citation Analysis]
127 Kostallari E, Wei B, Sicard D, Li J, Cooper SA, Gao J, Dehankar M, Li Y, Cao S, Yin M, Tschumperlin DJ, Shah VH. Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2022;322:G234-46. [PMID: 34941452 DOI: 10.1152/ajpgi.00254.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
128 Pudewell S, Lissy J, Nakhaeizadeh H, Taha MS, Akbarzadeh M, Rezaei Adariani S, Nakhaei-Rad S, Li J, Kordes C, Häussinger D, Piekorz RP, Cortese-Krott MM, Ahmadian MR. Physical Interaction between Embryonic Stem Cell-Expressed Ras (ERas) and Arginase-1 in Quiescent Hepatic Stellate Cells. Cells 2022;11:508. [PMID: 35159317 DOI: 10.3390/cells11030508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Wang A, Bu FT, Li JJ, Zhang YF, Jia PC, You HM, Wu S, Wu YY, Zhu S, Huang C, Li J. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression. Toxicol Lett 2022;355:88-99. [PMID: 34838997 DOI: 10.1016/j.toxlet.2021.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Niu L, Geyer PE, Gupta R, Santos A, Meier F, Doll S, Albrechtsen NJW, Klein S, Ortiz C, Uschner FE, Schierwagen R, Trebicka J, Mann M. Dynamic human liver proteome atlas reveals functional insights into disease pathways.. [DOI: 10.1101/2022.01.28.478194] [Reference Citation Analysis]
131 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
132 Werner M, Schefczyk S, Trippler M, Treckmann JW, Baba HA, Gerken G, Schlaak JF, Broering R. Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3. Viruses 2022;14:218. [DOI: 10.3390/v14020218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Mansouri M, Beemer S, Kothapalli CR, Rhoades T, Fodor PS, Das D, Leipzig ND. Generation of Oxygenating Fluorinated Methacrylamide Chitosan Microparticles to Increase Cell Survival and Function in Large Liver Spheroids. ACS Appl Mater Interfaces. [DOI: 10.1021/acsami.1c19962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Vargas-Pozada EE, Ramos-Tovar E, Acero-Hernández C, Cardoso-Lezama I, Galindo-Gómez S, Tsutsumi V, Muriel P. Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways. Ann Hepatol 2022;27:100671. [PMID: 35065262 DOI: 10.1016/j.aohep.2022.100671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
135 Brougham-Cook A, Jain I, Kukla DA, Masood F, Kimmel H, Ryoo H, Khetani SR, Underhill GH. High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype. Acta Biomater 2022;138:240-53. [PMID: 34800715 DOI: 10.1016/j.actbio.2021.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
136 Hammad S, Ogris C, Othman A, Erdoesi P, Schmidt-heck W, Biermayer I, Helm B, Gao Y, Piorońska W, D’alessandro LA, Theis FJ, Ebert MP, Klingmüller U, Hengstler JG, Dooley S, Mueller NS. Repeated toxic injuries of murine liver are tolerated through microsteatosis and mild inflammation.. [DOI: 10.1101/2022.01.12.476054] [Reference Citation Analysis]
137 赵 思. Overview of the Therapeutic Mechanism of Liver Fibrosis Based on Hepatic Stellate Cells. ACM 2022;12:4810-4816. [DOI: 10.12677/acm.2022.125698] [Reference Citation Analysis]
138 Gabbiani G, Coen M, Zampieri F. Fibrotic diseases. Wound Healing, Fibrosis, and the Myofibroblast 2022. [DOI: 10.1016/b978-0-323-90546-6.00007-1] [Reference Citation Analysis]
139 Kim J, Yun YH, Jung Y. Therapeutic Potential of MicroRNAs and Their Nanoparticle-based Delivery in the Treatment of Liver Fibrosis. Biotechnologies for Gene Therapy 2022. [DOI: 10.1007/978-3-030-93333-3_1] [Reference Citation Analysis]
140 Li W, Chen JY, Sun C, Sparks RP, Pantano L, Rahman RU, Moran SP, Pondick JV, Kirchner R, Wrobel D, Bieler M, Sauer A, Ho Sui SJ, Doerner JF, Rippmann JF, Mullen AC. Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells. Elife 2022;11. [PMID: 35617485 DOI: 10.7554/eLife.74513] [Reference Citation Analysis]
141 Wagner C, Hois V, Eggeling A, Pusch L, Pajed L, Starlinger P, Claudel T, Trauner M, Zimmermann R, Taschler U, Lass A. KIAA1363 affects retinyl ester turnover in cultured murine and human hepatic stellate cells. Journal of Lipid Research 2022. [DOI: 10.1016/j.jlr.2022.100173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Ramani K, Mavila N, Abeynayake A, Tomasi ML, Wang J, Matsuda M, Seki E. Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models. Elife 2022;11. [PMID: 36193675 DOI: 10.7554/eLife.78430] [Reference Citation Analysis]
143 Siegel PM, Nyström H, Brodt P. The tumor microenvironment of colorectal cancer liver metastases: Molecular mediators and future therapeutic targets. Contemporary Management of Metastatic Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-91706-3.00011-4] [Reference Citation Analysis]
144 Muriel P. Cells, cytokines, and factors involved in profibrogenic pathways. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00014-7] [Reference Citation Analysis]
145 Lee YA, Friedman SL. Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies. J Intern Med 2022;291:11-31. [PMID: 34564899 DOI: 10.1111/joim.13380] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
146 Fawwaz BAB, Farooq A, Guo M, Singh G, Ahmad S. Cathepsin B: structure, function, tumorigenesis, and prognostic value in hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 2022. [DOI: 10.1016/b978-0-323-99283-1.00014-8] [Reference Citation Analysis]
147 Maharjan S, Bonilla D, Zhang YS. 3D Bioprinting for Liver Regeneration. 3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine 2022. [DOI: 10.1016/b978-0-12-824552-1.00010-4] [Reference Citation Analysis]
148 Fitzpatrick E. Nonalcoholic Fatty Liver Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2022. [DOI: 10.1007/978-3-030-80068-0_69] [Reference Citation Analysis]
149 Wei XJ, Chen TQ, Yang XJ. Telocytes in Fibrosis Diseases: From Current Findings to Future Clinical Perspectives. Cell Transplant 2022;31:9636897221105252. [PMID: 35748420 DOI: 10.1177/09636897221105252] [Reference Citation Analysis]
150 Nash MJ, Dobrinskikh E, Newsom SA, Messaoudi I, Janssen RC, Aagaard KM, McCurdy CE, Gannon M, Kievit P, Friedman JE, Wesolowski SR. Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring. JCI Insight 2021;6:e154093. [PMID: 34935645 DOI: 10.1172/jci.insight.154093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
151 Dutta S, Prasad Mishra S, Kumar Sahu A, Mishra K, Kashyap P, Sahu B. Hepatocytes and Their Role in Metabolism. Drug Metabolism 2021. [DOI: 10.5772/intechopen.99083] [Reference Citation Analysis]
152 Kang Y, Cai Y, Yang Y. The gut microbiome and hepatocellular carcinoma: Implications for early diagnostic biomarkers and novel therapies. Liver Cancer. [DOI: 10.1159/000521358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
153 Delgado ME, Cárdenas BI, Farran N, Fernandez M. Metabolic Reprogramming of Liver Fibrosis. Cells 2021;10:3604. [PMID: 34944111 DOI: 10.3390/cells10123604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
154 Li Z, Chiang YP, He M, Worgall TS, Zhou H, Jiang XC. Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation. iScience 2021;24:103449. [PMID: 34927020 DOI: 10.1016/j.isci.2021.103449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
155 Koui Y, Himeno M, Mori Y, Nakano Y, Saijou E, Tanimizu N, Kamiya Y, Anzai H, Maeda N, Wang L, Yamada T, Sakai Y, Nakato R, Miyajima A, Kido T. Development of human iPSC-derived quiescent hepatic stellate cell-like cells for drug discovery and in vitro disease modeling. Stem Cell Reports 2021;16:3050-63. [PMID: 34861166 DOI: 10.1016/j.stemcr.2021.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Lee SW, Kim SM, Hur W, Kang BY, Lee HL, Nam H, Yoo SH, Sung PS, Kwon JH, Jang JW, Kim SJ, Yoon SK. Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway. PLoS One 2021;16:e0261067. [PMID: 34879114 DOI: 10.1371/journal.pone.0261067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
157 Francisco AB, Li J, Farghli AR, Kanke M, Shui B, Soloway PD, Wang Z, Reid LM, Liu J, Sethupathy P. Chemical, molecular, and single cell analysis reveal chondroitin sulfate proteoglycan aberrancy in fibrolamellar carcinoma.. [DOI: 10.1101/2021.12.07.471610] [Reference Citation Analysis]
158 Jia W, Liang S, Cheng B, Ling C. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Front Oncol 2021;11:763519. [PMID: 34868982 DOI: 10.3389/fonc.2021.763519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Allam A, Yakou M, Pang L, Ernst M, Huynh J. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy. Front Immunol 2021;12:767939. [PMID: 34858425 DOI: 10.3389/fimmu.2021.767939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
160 Cao D, Shamsan E, Jiang B, Fan H, Zhang Y, Dehwah MAS. Structural changes and expression of hepatic fibrosis-related proteins in coculture of Echinococcus multilocularis protoscoleces and human hepatic stellate cells. Parasit Vectors 2021;14:593. [PMID: 34857049 DOI: 10.1186/s13071-021-05037-1] [Reference Citation Analysis]
161 Castro-Gil MP, Torres-Mena JE, Salgado RM, Muñoz-Montero SA, Martínez-Garcés JM, López-Torres CD, Mendoza-Vargas A, Gabiño-López NB, Villa-Treviño S, Del Pozo-Yauner L, Arellanes-Robledo J, Krötzsch E, Pérez-Carreón JI. The transcriptome of early GGT/KRT19-positive hepatocellular carcinoma reveals a downregulated gene expression profile associated with fatty acid metabolism. Genomics 2021;114:72-83. [PMID: 34861383 DOI: 10.1016/j.ygeno.2021.11.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
162 Rios RS, Zheng KI, Zheng MH. Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma. Chin Med J (Engl) 2021;134:2911-21. [PMID: 34855640 DOI: 10.1097/CM9.0000000000001888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
163 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
164 Zheng B, Gao Z, Liang L, Lu Y, Kong Y, Chen W, Lin K, Chen W, Mai J, Li Y, Ma C. Autophagy of hepatic stellate cell induced by Clonorchis sinensis. Mol Biol Rep 2021. [PMID: 34825320 DOI: 10.1007/s11033-021-07001-9] [Reference Citation Analysis]
165 Herrero A, Knetemann E, Mannaerts I. Review: Challenges of In Vitro CAF Modelling in Liver Cancers. Cancers (Basel) 2021;13:5914. [PMID: 34885024 DOI: 10.3390/cancers13235914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Li T, Liu J, Wang Y, Zhou C, Shi Q, Huang S, Yang C, Chen Y, Bai Y, Xiong B. Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model. Sci Rep 2021;11:22846. [PMID: 34819565 DOI: 10.1038/s41598-021-02155-9] [Reference Citation Analysis]
167 Choi Y, Kim MS, Rhoades JH, Johnson NM, Berry CT, Root S, Chen Q, Tian Y, Fernandez RJ, Cramer Z, Adams-tzivelekidis S, Li N, Johnson FB, Lengner CJ. Patient induced pluripotent stem cell-derived hepatostellate organoids establish a basis for liver pathologies in telomeropathies.. [DOI: 10.1101/2021.11.19.469258] [Reference Citation Analysis]
168 Cho SS, Lee JH, Kim KM, Park EY, Ku SK, Cho IJ, Yang JH, Ki SH. REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway. Free Radic Biol Med 2021;176:246-56. [PMID: 34614448 DOI: 10.1016/j.freeradbiomed.2021.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
169 Su Q, Kim SY, Adewale F, Zhou Y, Aldler C, Ni M, Wei Y, Burczynski ME, Atwal GS, Sleeman MW, Murphy AJ, Xin Y, Cheng X. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 2021;24:103233. [PMID: 34755088 DOI: 10.1016/j.isci.2021.103233] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
170 Huang YJ, Cao J, Lee CY, Wu YM. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis. Stem Cell Res Ther 2021;12:568. [PMID: 34772443 DOI: 10.1186/s13287-021-02641-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
171 Xu Y, Chen J, Jiang W, Zhao Y, Yang C, Wu Y, Li Q, Zhu C. Multiplexing Nanodrug Ameliorates Liver Fibrosis via ROS Elimination and Inflammation Suppression. Small 2021;:e2102848. [PMID: 34758098 DOI: 10.1002/smll.202102848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
172 Kisoh K, Sugahara G, Ogawa Y, Furukawa S, Ishida Y, Okanoue T, Kohara M, Tateno C. Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers. Biomedicines 2021;9:1647. [PMID: 34829876 DOI: 10.3390/biomedicines9111647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Larson EL, Joo DJ, Nelson ED, Amiot BP, Aravalli RN, Nyberg SL. Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production. Stem Cell Reports 2021;16:2577-88. [PMID: 34678209 DOI: 10.1016/j.stemcr.2021.09.018] [Reference Citation Analysis]
174 Saber APR, Noshahry F. Study on association of non-alcoholic fatty liver disease and serum vitamin A, E, and selenium levels in high-fat fed diet rats. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-01008-5] [Reference Citation Analysis]
175 Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res 2021;70. [PMID: 34717063 DOI: 10.33549/physiolres.934755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
176 Li W, Deng M, Gong J, Zhang X, Ge S, Zhao L. Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun Signaling. Front Nutr 2021;8:729583. [PMID: 34660662 DOI: 10.3389/fnut.2021.729583] [Reference Citation Analysis]
177 Caligiuri A, Gentilini A, Pastore M, Gitto S, Marra F. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells 2021;10:2759. [PMID: 34685739 DOI: 10.3390/cells10102759] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
178 Carson JP, Robinson MW, Ramm GA, Gobert GN. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation. Mol Biol Rep 2021;48:7677-88. [PMID: 34648138 DOI: 10.1007/s11033-021-06774-3] [Reference Citation Analysis]
179 Chen X, Tang Y, Chen S, Ling W, Wang Q. IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study. Endocr Connect 2021;10:1315-25. [PMID: 34524971 DOI: 10.1530/EC-21-0353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
181 Li W, Chen JY, Sun C, Sparks RP, Pantano L, Rahman R, Moran SP, Pondick JV, Kirchner R, Wrobel D, Bieler M, Ho Sui SJ, Doerner JF, Rippmann JF, Mullen AC. Nanchangmycin regulates FYN, FAK and ERK to control the fibrotic activity of hepatic stellate cells.. [DOI: 10.1101/2021.10.08.463221] [Reference Citation Analysis]
182 Sánchez PS, Rigual MDM, Djouder N. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development. Cancers (Basel) 2021;13:5045. [PMID: 34680192 DOI: 10.3390/cancers13205045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Ding H, Yang X, Tian J, Wang X, Ji Y, El-Ashram S, Ren C, Shen J, Liu M. JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation. Biomed Pharmacother 2021;144:112281. [PMID: 34624676 DOI: 10.1016/j.biopha.2021.112281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Satilmis B, Sahin TT, Cicek E, Akbulut S, Yilmaz S. Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics. J Gastrointest Cancer 2021. [PMID: 34625923 DOI: 10.1007/s12029-021-00725-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
185 Pluta KD, Ciezkowska M, Wisniewska M, Wencel A, Pijanowska DG. Cell-based clinical and experimental methods for assisting the function of impaired livers – Present and future of liver support systems. Biocybernetics and Biomedical Engineering 2021;41:1322-46. [DOI: 10.1016/j.bbe.2021.06.005] [Reference Citation Analysis]
186 Aloia L. The influence of tissue spatial geometry and functional organisation on liver regeneration. Semin Cell Dev Biol 2021:S1084-9521(21)00246-9. [PMID: 34563460 DOI: 10.1016/j.semcdb.2021.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Kostrzewski T, Snow S, Battle AL, Peel S, Ahmad Z, Basak J, Surakala M, Bornot A, Lindgren J, Ryaboshapkina M, Clausen M, Lindén D, Maass C, Young LM, Corrigan A, Ewart L, Hughes D. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Commun Biol 2021;4:1080. [PMID: 34526653 DOI: 10.1038/s42003-021-02616-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
188 Pohl K, Moodley P, Dhanda AD. Alcohol's Impact on the Gut and Liver. Nutrients 2021;13:3170. [PMID: 34579046 DOI: 10.3390/nu13093170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
189 Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab 2021;33:1744-62. [PMID: 34496230 DOI: 10.1016/j.cmet.2021.08.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 21.0] [Reference Citation Analysis]
190 Momen-Heravi F, Catalano D, Talis A, Szabo G, Bala S. Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice. Mol Ther Nucleic Acids 2021;25:155-67. [PMID: 34458001 DOI: 10.1016/j.omtn.2021.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
191 Biagioli M, Fiorucci S. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease. Liver Research 2021;5:119-41. [DOI: 10.1016/j.livres.2021.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
192 Xing Z, Wu Y, Liu N. IL-22 alleviates the fibrosis of hepatic stellate cells via the inactivation of NLRP3 inflammasome signaling. Exp Ther Med 2021;22:1088. [PMID: 34447480 DOI: 10.3892/etm.2021.10522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
193 Cierpka R, Weiskirchen R, Asimakopoulos A. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation. Cells 2021;10:2184. [PMID: 34571833 DOI: 10.3390/cells10092184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
194 Kang MJ, Lee S, Jung U, Mandal C, Park H, Stetler-Stevenson WG, Kim YS, Moon JW, Park SH, Oh J. Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice. Am J Pathol 2021:S0002-9440(21)00352-7. [PMID: 34428424 DOI: 10.1016/j.ajpath.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
195 Long C, Xie N, Shu Y, Wu Y, He P, Zhou Y, Xiang Y, Gu J, Yang L, Wang Y. Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis. Med Sci Monit 2021;27:e931236. [PMID: 34413280 DOI: 10.12659/MSM.931236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Zhang W, Conway SJ, Liu Y, Snider P, Chen H, Gao H, Liu Y, Isidan K, Lopez KJ, Campana G, Li P, Ekser B, Francis H, Shou W, Kubal C. Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury. Cells 2021;10:2129. [PMID: 34440898 DOI: 10.3390/cells10082129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
197 Xiong Y, Huang J. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment. Chin Med 2021;16:80. [PMID: 34407830 DOI: 10.1186/s13020-021-00489-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Lee J, Kim SR, Lee C, Jun YI, Bae S, Yoon YJ, Kim OY, Gho YS. Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride. J Extracell Vesicles 2021;10:e12133. [PMID: 34401049 DOI: 10.1002/jev2.12133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
199 Wu M, Miao H, Fu R, Zhang J, Zheng W. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma. Curr Mol Pharmacol 2020;13:261-72. [PMID: 32091349 DOI: 10.2174/1874467213666200224102820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
200 Ben-moshe S, Veg T, Manco R, Dan S, Kolodziejczyk AA, Halpern KB, Elinav E, Itzkovitz S. The spatio-temporal program of liver zonal regeneration.. [DOI: 10.1101/2021.08.11.455924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Yamaguchi M, Dohi N, Ooka A, Saito SY, Ishikawa T. Caffeine-induced inversion of prostaglandin E2 effects on hepatic stellate cell activation. Biomed Pharmacother 2021;142:111989. [PMID: 34388524 DOI: 10.1016/j.biopha.2021.111989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Carter J, Wang S, Friedman SL. Ten Thousand Points of Light: Heterogeneity Among the Stars of NASH Fibrosis. Hepatology 2021;74:543-6. [PMID: 33724489 DOI: 10.1002/hep.31807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
204 Sisto M, Ribatti D, Lisi S. ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer. J Clin Med 2021;10:3373. [PMID: 34362154 DOI: 10.3390/jcm10153373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
205 Molenaar MR, Yadav KK, Toulmay A, Wassenaar TA, Mari MC, Caillon L, Chorlay A, Lukmantara IE, Haaker MW, Wubbolts RW, Houweling M, Vaandrager AB, Prieur X, Reggiori F, Choudhary V, Yang H, Schneiter R, Thiam AR, Prinz WA, Helms JB. Retinyl esters form lipid droplets independently of triacylglycerol and seipin. J Cell Biol 2021;220:e202011071. [PMID: 34323918 DOI: 10.1083/jcb.202011071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
206 Lee HY, Nga HT, Tian J, Yi HS. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma. Cells 2021;10:1901. [PMID: 34440674 DOI: 10.3390/cells10081901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
207 Gu Y, Bi Y, Wei H, Li J, Huang Z, Liao C, Liao W, Huang Y. Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients: A cross-sectional study. Medicine (Baltimore) 2021;100:e26667. [PMID: 34398030 DOI: 10.1097/MD.0000000000026667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J. Extracellular Matrix Remodeling in Chronic Liver Disease. Curr Tissue Microenviron Rep 2021;:1-12. [PMID: 34337431 DOI: 10.1007/s43152-021-00030-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
209 You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. FASEB J 2021;35:e21700. [PMID: 34105828 DOI: 10.1096/fj.202002319RRR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
210 Gao L, Morine Y, Yamada S, Saito Y, Ikemoto T, Tokuda K, Miyazaki K, Okikawa S, Takasu C, Shimada M. The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts. Cancer Sci 2021;112:3545-54. [PMID: 34159680 DOI: 10.1111/cas.15041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
211 Cui ZY, Wang G, Zhang J, Song J, Jiang YC, Dou JY, Lian LH, Nan JX, Wu YL. Parthenolide, bioactive compound of Chrysanthemum parthenium L., ameliorates fibrogenesis and inflammation in hepatic fibrosis via regulating the crosstalk of TLR4 and STAT3 signaling pathway. Phytother Res 2021. [PMID: 34250656 DOI: 10.1002/ptr.7214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
212 Devi P, Khan A, Chattopadhyay P, Mehta P, Sahni S, Sharma S, Pandey R. Co-infections as Modulators of Disease Outcome: Minor Players or Major Players? Front Microbiol 2021;12:664386. [PMID: 34295314 DOI: 10.3389/fmicb.2021.664386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
213 Aksakal M, Oktar SO, Sendur HN, Esendaglı G, Ozenirler S, Cindoruk M, Hızel K. Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: a histopathological correlation study. Abdom Radiol (NY) 2021;46:3238-44. [PMID: 33723676 DOI: 10.1007/s00261-021-03019-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
214 Tsang HY, Yi Lo PH, Ho Lee KK. Generation of liver organoids from human induced pluripotent stem cells as liver fibrosis and steatosis models.. [DOI: 10.1101/2021.06.29.450347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
215 Okuyama S, Kawamura F, Kubiura M, Tsuji S, Osaki M, Kugoh H, Oshimura M, Kazuki Y, Tada M. Real-time fluorometric evaluation of hepatoblast proliferation in vivo and in vitro using the expression of CYP3A7 coding for human fetus-specific P450. Pharmacol Res Perspect 2020;8:e00642. [PMID: 32886454 DOI: 10.1002/prp2.642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
216 Bourebaba N, Marycz K. Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview. Pharmacol Res 2021;170:105739. [PMID: 34171492 DOI: 10.1016/j.phrs.2021.105739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
217 Ho CH, Huang JH, Sun MS, Tzeng IS, Hsu YC, Kuo CY. Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis. Evid Based Complement Alternat Med 2021;2021:6671129. [PMID: 34239589 DOI: 10.1155/2021/6671129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
218 Abd El Hady Mousa M, Mansour H, Eid F, Mashaal A. Anti-inflammatory activity of ginger modulates macrophage activation against the inflammatory pathway of monosodium glutamate. J Food Biochem 2021;:e13819. [PMID: 34159624 DOI: 10.1111/jfbc.13819] [Reference Citation Analysis]
219 Zhang B, Lapenta K, Wang Q, Nam JH, Chung D, Robert ME, Nathanson MH, Yang X. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. J Biol Chem 2021;297:100887. [PMID: 34146542 DOI: 10.1016/j.jbc.2021.100887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Kukla DA, Khetani SR. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Semin Liver Dis 2021;41:368-92. [PMID: 34139785 DOI: 10.1055/s-0041-1731016] [Reference Citation Analysis]
221 Baglieri J, Zhang C, Liang S, Liu X, Nishio T, Rosenthal SB, Dhar D, Su H, Cong M, Jia J, Hosseini M, Karin M, Kisseleva T, Brenner DA. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice. Am J Pathol 2021;191:1564-79. [PMID: 34119473 DOI: 10.1016/j.ajpath.2021.05.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
222 Qian H, Chao X, Williams J, Fulte S, Li T, Yang L, Ding WX. Autophagy in liver diseases: A review. Mol Aspects Med 2021;:100973. [PMID: 34120768 DOI: 10.1016/j.mam.2021.100973] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
223 Daou N, Viader A, Cokol M, Nitzel A, Chakravarthy MV, Afeyan R, Tramontin T, Marukian S, Hamill MJ. A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models. Sci Rep 2021;11:11861. [PMID: 34088912 DOI: 10.1038/s41598-021-88913-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Escutia-Gutiérrez R, Rodríguez-Sanabria JS, Monraz-Méndez CA, García-Bañuelos J, Santos-García A, Sandoval-Rodríguez A, Armendáriz-Borunda J. Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH. Sci Rep 2021;11:11709. [PMID: 34083664 DOI: 10.1038/s41598-021-91187-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
225 Li H, Ding P, Peng B, Ming YZ. Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis. Hepatobiliary Pancreat Dis Int 2021;20:207-14. [PMID: 33972160 DOI: 10.1016/j.hbpd.2021.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
226 Xie X, Dou CY, Zhou Y, Zhou Q, Tang HB. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis. Dig Dis Sci 2021;66:1928-39. [PMID: 32648079 DOI: 10.1007/s10620-020-06460-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
227 Saadat M, Mostafaei F, Mahdinloo S, Abdi M, Zahednezhad F, Zakeri-milani P, Valizadeh H. Drug delivery of pH-Sensitive nanoparticles into the liver cancer cells. Journal of Drug Delivery Science and Technology 2021;63:102557. [DOI: 10.1016/j.jddst.2021.102557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
228 Salunkhe SA, Chitkara D, Mahato RI, Mittal A. Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis. Adv Drug Deliv Rev 2021;173:394-415. [PMID: 33831474 DOI: 10.1016/j.addr.2021.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
229 Wu X, Shu L, Zhang Z, Li J, Zong J, Cheong LY, Ye D, Lam KSL, Song E, Wang C, Xu A, Hoo RLC. Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. Adv Sci (Weinh) 2021;8:e2003721. [PMID: 34105268 DOI: 10.1002/advs.202003721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
230 Manicardi N, Fernández-Iglesias A, Abad-Jordà L, Royo F, Azkargorta M, Ortega-Ribera M, Sanfeliu-Redondo D, Martínez-Alcocer A, Elortza F, Hessheimer AJ, Fondevila C, Lozano JJ, García-Pagán JC, Bosch J, Cubero FJ, Albillos A, Vaquero J, Falcón-Pérez JM, Gracia-Sancho J. Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers (Basel) 2021;13:2688. [PMID: 34072510 DOI: 10.3390/cancers13112688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
231 Shi YS, Li XX, Li HT, Zhang Y. Pelargonidin ameliorates CCl4-induced liver fibrosis by suppressing the ROS-NLRP3-IL-1β axis via activating the Nrf2 pathway. Food Funct 2020;11:5156-65. [PMID: 32432601 DOI: 10.1039/d0fo00660b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
232 Yao T, Zhang Y, Lv M, Zang G, Ng SS, Chen X. Advances in 3D cell culture for liver preclinical studies. Acta Biochim Biophys Sin (Shanghai) 2021;53:643-51. [PMID: 33973620 DOI: 10.1093/abbs/gmab046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Bravo M, Raurell I, Barberá A, Hide D, Gil M, Estrella F, Salcedo MT, Augustin S, Genescà J, Martell M. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH. Dis Model Mech 2021;14:dmm048884. [PMID: 34014280 DOI: 10.1242/dmm.048884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
234 Kordes C, Bock HH, Reichert D, May P, Häussinger D. Hepatic stellate cells: current state and open questions. Biol Chem 2021;402:1021-32. [PMID: 34008380 DOI: 10.1515/hsz-2021-0180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
235 Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. Int J Mol Sci 2021;22:5038. [PMID: 34068678 DOI: 10.3390/ijms22095038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
236 Reungoat E, Grigorov B, Zoulim F, Pécheur EI. Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. Cancers (Basel) 2021;13:2270. [PMID: 34065048 DOI: 10.3390/cancers13092270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Matye DJ, Wang H, Luo W, Sharp RR, Chen C, Gu L, Jones KL, Ding WX, Friedman JE, Li T. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol 2021;12:1001-19. [PMID: 33965587 DOI: 10.1016/j.jcmgh.2021.04.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
238 Harrison SP, Baumgarten SF, Verma R, Lunov O, Dejneka A, Sullivan GJ. Liver Organoids: Recent Developments, Limitations and Potential. Front Med (Lausanne) 2021;8:574047. [PMID: 34026769 DOI: 10.3389/fmed.2021.574047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
239 Petersen OH, Gerasimenko JV, Gerasimenko OV, Gryshchenko O, Peng S. The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas. Physiol Rev 2021;101:1691-744. [PMID: 33949875 DOI: 10.1152/physrev.00003.2021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
240 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
241 Nagle MP, Tam GS, Maltz E, Hemminger Z, Wollman R. Bridging scales: From cell biology to physiology using in situ single-cell technologies. Cell Syst 2021;12:388-400. [PMID: 34015260 DOI: 10.1016/j.cels.2021.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
242 Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 2021;39:866-882.e11. [PMID: 33930309 DOI: 10.1016/j.ccell.2021.03.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
243 Große-Segerath L, Lammert E. Role of vasodilation in liver regeneration and health. Biol Chem 2021;402:1009-19. [PMID: 33908220 DOI: 10.1515/hsz-2021-0155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
244 Yan L, Zhang X, Fu J, Liu Q, Lei X, Cao Z, Zhang J, Shao Y, Tong Q, Qin W, Liu X, Liu C, Liu Z, Li Z, Lu J, Xu X. Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis. Biochem Biophys Res Commun 2021;558:86-93. [PMID: 33906111 DOI: 10.1016/j.bbrc.2021.04.065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
245 Messner CJ, Babrak L, Titolo G, Caj M, Miho E, Suter-Dick L. Single Cell Gene Expression Analysis in a 3D Microtissue Liver Model Reveals Cell Type-Specific Responses to Pro-Fibrotic TGF-β1 Stimulation. Int J Mol Sci 2021;22:4372. [PMID: 33922101 DOI: 10.3390/ijms22094372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Chen S, Guo H, Xie M, Zhou C, Zheng M. Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease. Int Immunopharmacol 2021;97:107609. [PMID: 33887577 DOI: 10.1016/j.intimp.2021.107609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
247 Vallverdú J, Martínez García de la Torre RA, Mannaerts I, Verhulst S, Smout A, Coll M, Ariño S, Rubio-Tomás T, Aguilar-Bravo B, Martínez-Sánchez C, Blaya D, Verfaillie CM, van Grunsven LA, Sancho-Bru P. Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells. Nat Protoc 2021;16:2542-63. [PMID: 33864055 DOI: 10.1038/s41596-021-00509-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
248 Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D'Angelica MI, Endo I, Parks RW, Doyle M, de Santibañes E, Pawlik TM. Liver metastases. Nat Rev Dis Primers 2021;7:27. [PMID: 33859205 DOI: 10.1038/s41572-021-00261-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
249 Zhang F, Wang F, He J, Lian N, Wang Z, Shao J, Ding H, Tan S, Chen A, Zhang Z, Wang S, Zheng S. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1. Br J Pharmacol 2021;178:2246-65. [PMID: 33085791 DOI: 10.1111/bph.15289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
250 Betsou A, Lambropoulou M, Georgakopoulou AE, Kostomitsopoulos N, Konstandi O, Anagnostopoulos K, Tsalikidis C, Simopoulos CE, Valsami G, Tsaroucha AK. The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR. J Pharm Pharmacol 2021:rgab062. [PMID: 33847359 DOI: 10.1093/jpp/rgab062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Rodewald M, Bae H, Huschke S, Meyer-Zedler T, Schmitt M, Press AT, Schubert S, Bauer M, Popp J. In vivo coherent anti-Stokes Raman scattering microscopy reveals vitamin A distribution in the liver. J Biophotonics 2021;14:e202100040. [PMID: 33720518 DOI: 10.1002/jbio.202100040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
252 Sufleţel RT, Melincovici CS, Gheban BA, Toader Z, Mihu CM. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol 2020;61:615-42. [PMID: 33817704 DOI: 10.47162/RJME.61.3.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
253 Myojin Y, Hikita H, Sugiyama M, Sasaki Y, Fukumoto K, Sakane S, Makino Y, Takemura N, Yamada R, Shigekawa M, Kodama T, Sakamori R, Kobayashi S, Tatsumi T, Suemizu H, Eguchi H, Kokudo N, Mizokami M, Takehara T. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production. Gastroenterology 2021;160:1741-1754.e16. [PMID: 33346004 DOI: 10.1053/j.gastro.2020.12.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
254 Park YJ, Jeon MS, Lee S, Kim JK, Jang TS, Chung KH, Kim KH. Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway. Bioorg Med Chem Lett 2021;41:127989. [PMID: 33794317 DOI: 10.1016/j.bmcl.2021.127989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
255 Zhong C, Li Y, Yang J, Jin S, Chen G, Li D, Fan X, Lin H. Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects. Front Oncol 2021;11:589680. [PMID: 33854960 DOI: 10.3389/fonc.2021.589680] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
256 Nabil A, Uto K, Zahran F, Soliman R, Hassan AA, Elshemy MM, Ali IS, Ebara M, Shiha G. The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. Biomed Res Int 2021;2021:6678913. [PMID: 33855079 DOI: 10.1155/2021/6678913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
257 Azzam A, Jiyad Z, O'Beirne J. Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis. Australas J Dermatol 2021;62:130-40. [PMID: 33769558 DOI: 10.1111/ajd.13546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
258 Han B, Mo H, Svarovskaia E, Mateo R. A primary human hepatocyte/hepatic stellate cell co-culture system for improved in vitro HBV replication. Virology 2021;559:40-5. [PMID: 33813211 DOI: 10.1016/j.virol.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
259 Xia Y, Zhen L, Li H, Wang S, Chen S, Wang C, Yang X. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway. Cell Death Dis 2021;12:326. [PMID: 33771969 DOI: 10.1038/s41419-021-03494-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
260 Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
261 Li T, Yang H, Li X, Hou Y, Zhao Y, Wu W, Zhao L, Wang F, Zhao Z. Open-flow microperfusion combined with mass spectrometry for in vivo liver lipidomic analysis. Analyst 2021;146:1915-23. [PMID: 33481970 DOI: 10.1039/d0an02189j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Chen X, Niu X, Liu Y, Zheng R, Wang L, Yang L, Lu J, Yin S, Shao Y, Wei Y, Pan J, Sayed A, Ma X, Liu M, Jing F, Liu M, Hu J, Zhang X, Li D. Amelioration of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration.. [DOI: 10.1101/2021.03.18.435908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
263 Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A. Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases. Int J Mol Sci 2021;22:3113. [PMID: 33803718 DOI: 10.3390/ijms22063113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
264 Wang F, Malnassy G, Qiu W. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Front Oncol 2021;11:653037. [PMID: 33791228 DOI: 10.3389/fonc.2021.653037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
265 Geervliet E, Moreno S, Baiamonte L, Booijink R, Boye S, Wang P, Voit B, Lederer A, Appelhans D, Bansal R. Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis. J Control Release 2021;332:594-607. [PMID: 33737203 DOI: 10.1016/j.jconrel.2021.03.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
266 Liao YJ, Wang YH, Wu CY, Hsu FY, Chien CY, Lee YC. Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice. Int J Mol Sci 2021;22:2934. [PMID: 33805788 DOI: 10.3390/ijms22062934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
267 Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, Sun BY, Wang ZT, Zhou J, Fan J, Qiu SJ, Yi Y. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death Dis 2021;12:260. [PMID: 33707417 DOI: 10.1038/s41419-021-03545-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
268 Riaz F, Chen Q, Lu K, Osoro EK, Wu L, Feng L, Zhao R, Yang L, Zhou Y, He Y, Zhu L, Du X, Sadiq M, Yang X, Li D. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. J Cell Mol Med 2021;25:4073-87. [PMID: 33689215 DOI: 10.1111/jcmm.16376] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
269 He C, Shu B, Zhou Y, Zhang R, Yang X. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl4-induced hepatic fibrosis in mice. Life Sci 2021;276:119294. [PMID: 33675896 DOI: 10.1016/j.lfs.2021.119294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
270 Piras IS, Gerhard GS, DiStefano JK. Palmitate and Fructose Interact to Induce Human Hepatocytes to Produce Pro-Fibrotic Transcriptional Responses in Hepatic Stellate Cells Exposed to Conditioned Media. Cell Physiol Biochem 2020;54:1068-82. [PMID: 33095528 DOI: 10.33594/000000288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
271 Huang HM, Zhou XR, Liu YJ, Fan SJ, Liao LP, Huang J, Shi CC, Yu L, Pen JJ, Luo C, Zhang YY, Li GM. Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation. Mol Med Rep 2021;23:305. [PMID: 33649839 DOI: 10.3892/mmr.2021.11944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Xu A, Zhou J, Li Y, Qiao L, Jin C, Chen W, Sun L, Wu S, Li X, Zhou D, Jia S, Zhang B, Yao J, Zhang X, You H, Huang J. 14-kDa phosphohistidine phosphatase is a potential therapeutic target for liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G351-65. [PMID: 33406007 DOI: 10.1152/ajpgi.00334.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
273 Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, Zhang Z, Zhou J, Huang H, Tang Q, Huang C, Zhao Y, Zhang G, Jiang W, Mo L, Zhang J, Xie W, He J. Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells. Hepatology 2021;73:1140-57. [PMID: 32535965 DOI: 10.1002/hep.31418] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 20.5] [Reference Citation Analysis]
274 Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 2021;18:151-66. [PMID: 33128017 DOI: 10.1038/s41575-020-00372-7] [Cited by in Crossref: 274] [Cited by in F6Publishing: 262] [Article Influence: 137.0] [Reference Citation Analysis]
275 Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J Clin Med 2021;10:702. [PMID: 33670126 DOI: 10.3390/jcm10040702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
276 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
277 Wong JSL, Kwok GGW, Tang V, Li BCW, Leung R, Chiu J, Ma KW, She WH, Tsang J, Lo CM, Cheung TT, Yau T. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. J Immunother Cancer 2021;9:e001945. [PMID: 33563773 DOI: 10.1136/jitc-2020-001945] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
278 Maharjan S, Bonilla D, Sindurakar P, Li H, Li W, Duarte S, Zarrinpar A, Zhang YS. 3D human nonalcoholic hepatic steatosis and fibrosis models. Bio-des Manuf 2021;4:157-70. [DOI: 10.1007/s42242-020-00121-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
279 Wu Y, Cao Y, Xu K, Zhu Y, Qiao Y, Wu Y, Chen J, Li C, Zeng R, Ge G. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis. Cell Death Dis 2021;12:163. [PMID: 33558482 DOI: 10.1038/s41419-021-03443-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
280 Huang W, Ji R, Ge S, Zhou D, Liu Z, Sun Y, Huang W, Lu C. MicroRNA-92b-3p promotes the progression of liver fibrosis by targeting CREB3L2 through the JAK/STAT signaling pathway. Pathol Res Pract 2021;219:153367. [PMID: 33618248 DOI: 10.1016/j.prp.2021.153367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Martin K, Hatab A, Athwal VS, Jokl E, Piper Hanley K. Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. Curr Diab Rep 2021;21:8. [PMID: 33544287 DOI: 10.1007/s11892-021-01377-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
282 Park JH, Kim J, Choi SY, Lee B, Lee JE, Park H, Moon JW, Park SH, Lee JM, Lee HS, Oh J. Albumin inhibits the nuclear translocation of Smad3 via interleukin-1beta signaling in hepatic stellate cells. Sci Rep 2021;11:3196. [PMID: 33542418 DOI: 10.1038/s41598-021-82758-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
284 Czuba LC, Wu X, Huang W, Hollingshead N, Roberto JB, Kenerson HL, Yeung RS, Crispe IN, Isoherranen N. Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis. Clin Transl Sci 2021;14:976-89. [PMID: 33382909 DOI: 10.1111/cts.12962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
285 Sarkar J, Kamble SC, Kashikar NC. Polymeric Bioinks for 3D Hepatic Printing. Chemistry 2021;3:164-81. [DOI: 10.3390/chemistry3010014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
286 Zhu C, Tabas I, Schwabe RF, Pajvani UB. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. Nat Rev Gastroenterol Hepatol 2021;18:131-42. [PMID: 33051603 DOI: 10.1038/s41575-020-00365-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 18.0] [Reference Citation Analysis]
287 Son YJ, Jung DS, Shin JM, Kim M, Yoo G, Nho CW. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis. BMC Complement Med Ther 2021;21:44. [PMID: 33494735 DOI: 10.1186/s12906-021-03212-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
288 Hu M, Wang Y, Liu Z, Yu Z, Guan K, Liu M, Wang M, Tan J, Huang L. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nat Nanotechnol 2021;16:466-77. [PMID: 33495618 DOI: 10.1038/s41565-020-00836-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
289 Liao X, Zhan W, Li R, Tian T, Yu L, Yang Q. Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells. Biol Chem 2021;402:703-15. [PMID: 33951764 DOI: 10.1515/hsz-2020-0251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
290 Schwabl P, Hambruch E, Budas GR, Supper P, Burnet M, Liles JT, Birkel M, Brusilovskaya K, Königshofer P, Peck-Radosavljevic M, Watkins WJ, Trauner M, Breckenridge DG, Kremoser C, Reiberger T. The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. Biomedicines 2021;9:60. [PMID: 33435509 DOI: 10.3390/biomedicines9010060] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
291 Kurosawa T, Goto M, Kaji N, Aikiyo S, Mihara T, Ikemoto-Uezumi M, Toyoda M, Kanazawa N, Nakazawa T, Hori M, Uezumi A. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα. Cell Death Dis 2021;12:11. [PMID: 33414474 DOI: 10.1038/s41419-020-03353-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
292 Hwang I, Lee EJ, Park H, Moon D, Kim HS. Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis. Cell Biosci 2021;11:3. [PMID: 33407858 DOI: 10.1186/s13578-020-00509-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
293 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
294 Guragac Dereli FT, Guragac A, Belwal T. Introduction. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 2021. [DOI: 10.1016/b978-0-12-816488-4.00011-5] [Reference Citation Analysis]
295 Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021;18:615-25. [PMID: 33437196 DOI: 10.7150/ijms.51589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
296 Suzuki-kemuriyama N, Abe A, Nakane S, Uno K, Ogawa S, Watanabe A, Sano R, Yuki M, Miyajima K, Nakae D. Extract of <i>Siraitia grosvenorii</i> (Luo Han Guo) protects against hepatic fibrosis in mice on a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet without trans fatty acids. Fundam Toxicol Sci 2021;8:135-145. [DOI: 10.2131/fts.8.135] [Reference Citation Analysis]
297 Li B, Wang L, Bai W, Chen W, Chen F, Shu C. Anthocyanins in Health Protection. Anthocyanins 2021. [DOI: 10.1007/978-981-16-7055-8_14] [Reference Citation Analysis]
298 Zhang R, Huang X, Jiang Y, Wang J, Chen S. Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol 2020;2020:8887574. [PMID: 33381477 DOI: 10.1155/2020/8887574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
299 Zheng R, Fang X, Chen X, Huang Y, Xu G, He L, Li Y, Niu X, Yang L, Wang L, Li D, Geng H. Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1. Clin Transl Med 2020;10:e261. [PMID: 33377632 DOI: 10.1002/ctm2.261] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
300 Warner FJ, Rajapaksha H, Shackel N, Herath CB. ACE2: from protection of liver disease to propagation of COVID-19. Clin Sci (Lond). 2020;134:3137-3158. [PMID: 33284956 DOI: 10.1042/cs20201268] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
301 Kim J, Lee C, Shin Y, Wang S, Han J, Kim M, Kim JM, Shin SC, Lee BJ, Kim TJ, Jung Y. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Mol Ther 2021;29:1471-86. [PMID: 33348053 DOI: 10.1016/j.ymthe.2020.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
302 Urushima H, Yuasa H, Matsubara T, Kuroda N, Hara Y, Inoue K, Wake K, Sato T, Friedman SL, Ikeda K. Activation of Hepatic Stellate Cells Requires Dissociation of E-Cadherin-Containing Adherens Junctions with Hepatocytes. Am J Pathol 2021;191:438-53. [PMID: 33345995 DOI: 10.1016/j.ajpath.2020.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
303 Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther 2021;222:107791. [PMID: 33321113 DOI: 10.1016/j.pharmthera.2020.107791] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
304 Nathwani R, Mullish BH, Kockerling D, Forlano R, Manousou P, Dhar A. A Review of Liver Fibrosis and Emerging Therapies. EMJ 2020. [DOI: 10.33590/emj/10310892] [Reference Citation Analysis]
305 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
306 Wang R, Zhang D, Tang D, Sun K, Peng J, Zhu W, Yin S, Wu Y. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl4-induced hepatic fibrosis in rats in vivo. Int Immunopharmacol 2021;90:107151. [PMID: 33296784 DOI: 10.1016/j.intimp.2020.107151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
307 Guo J, Liu W, Zeng Z, Lin J, Zhang X, Chen L. Tgfb3 and Mmp13 regulated the initiation of liver fibrosis progression as dynamic network biomarkers. J Cell Mol Med 2021;25:867-79. [PMID: 33269546 DOI: 10.1111/jcmm.16140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
308 Chen Y, Li R, Hu N, Yu C, Song H, Li Y, Dai Y, Guo Z, Li M, Zheng Y, Guo Z, Qi Y. Baihe Wuyao decoction ameliorates CCl4-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects. Journal of Ethnopharmacology 2020;263:113227. [DOI: 10.1016/j.jep.2020.113227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
309 Ribatti D, Tamma R, Annese T. The role of vascular niche and endothelial cells in organogenesis and regeneration. Exp Cell Res 2021;398:112398. [PMID: 33271129 DOI: 10.1016/j.yexcr.2020.112398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
310 Freag MS, Namgung B, Reyna Fernandez ME, Gherardi E, Sengupta S, Jang HL. Human Nonalcoholic Steatohepatitis on a Chip. Hepatol Commun 2021;5:217-33. [PMID: 33553970 DOI: 10.1002/hep4.1647] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
311 Park YJ, Lee KH, Jeon MS, Lee YH, Ko YJ, Pang C, Kim B, Chung KH, Kim KH. Hepatoprotective Potency of Chrysophanol 8-O-Glucoside from Rheum palmatum L. against Hepatic Fibrosis via Regulation of the STAT3 Signaling Pathway. Int J Mol Sci 2020;21:E9044. [PMID: 33261209 DOI: 10.3390/ijms21239044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
312 Levy NA, Kern G, Shepshelovich D, Shibolet O, Hershkoviz R, Isakov O. Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study. Oncotarget 2020;11:4438-47. [PMID: 33315979 DOI: 10.18632/oncotarget.27820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
313 Trivedi P, Wang S, Friedman SL. The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells. Cell Metab 2021;33:242-57. [PMID: 33232666 DOI: 10.1016/j.cmet.2020.10.026] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 18.7] [Reference Citation Analysis]
314 Dominijanni A, Devarasetty M, Soker S. Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance. iScience 2020;23:101851. [PMID: 33319176 DOI: 10.1016/j.isci.2020.101851] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
315 Kühnl J, Tao TP, Brandmair K, Gerlach S, Rings T, Müller-Vieira U, Przibilla J, Genies C, Jaques-Jamin C, Schepky A, Marx U, Hewitt NJ, Maschmeyer I. Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model. Toxicology 2021;448:152637. [PMID: 33220337 DOI: 10.1016/j.tox.2020.152637] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
316 Lim HJ, Kim M. EZH2 as a Potential Target for NAFLD Therapy. Int J Mol Sci 2020;21:E8617. [PMID: 33207561 DOI: 10.3390/ijms21228617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
317 Kitto LJ, Henderson NC. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair. Hepatol Commun 2021;5:358-70. [PMID: 33681672 DOI: 10.1002/hep4.1628] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
318 Li X, Xing Y, Mao D, Ying L, Luan Y, Xu M, Wang H, Li C, Li Y, Zheng S, Li Z, Hu J, Li Z, Wang H, Luan Y. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl4-induced fibrotic mice model. Biomed Pharmacother 2021;133:110960. [PMID: 33197763 DOI: 10.1016/j.biopha.2020.110960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
319 Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Front Cell Infect Microbiol 2020;10:587628. [PMID: 33240824 DOI: 10.3389/fcimb.2020.587628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
320 Leslie J, Macia MG, Luli S, Worrell JC, Reilly WJ, Paish HL, Knox A, Barksby BS, Gee LM, Zaki MYW, Collins AL, Burgoyne RA, Cameron R, Bragg C, Xu X, Chung GW, Brown CDA, Blanchard AD, Nanthakumar CB, Karsdal M, Robinson SM, Manas DM, Sen G, French J, White SA, Murphy S, Trost M, Zakrzewski JL, Klein U, Schwabe RF, Mederacke I, Nixon C, Bird T, Teuwen LA, Schoonjans L, Carmeliet P, Mann J, Fisher AJ, Sheerin NS, Borthwick LA, Mann DA, Oakley F. c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis. Nat Metab 2020;2:1350-67. [PMID: 33168981 DOI: 10.1038/s42255-020-00306-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
321 Vilchis-landeros MM, Matuz-mares D, Vázquez-meza H. Regulation of Metabolic Processes by Hydrogen Peroxide Generated by NADPH Oxidases. Processes 2020;8:1424. [DOI: 10.3390/pr8111424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
322 Rai RP, Liu Y, Iyer SS, Liu S, Gupta B, Desai C, Kumar P, Smith T, Singhi AD, Nusrat A, Parkos CA, Monga SP, Czaja MJ, Anania FA, Raeman R. Blocking integrin α(4)β(7)-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. J Hepatol 2020;73:1013-22. [PMID: 32540177 DOI: 10.1016/j.jhep.2020.05.047] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
323 Hu S, Bae M, Park Y, Lee J. n-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells. The Journal of Nutritional Biochemistry 2020;85:108452. [DOI: 10.1016/j.jnutbio.2020.108452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
324 Wang K, Guo Z, Bao Y, Pang Y, Li Y, He H, Song D. Structure-Activity Relationship of Aloperine Derivatives as New Anti-Liver Fibrogenic Agents. Molecules 2020;25:E4977. [PMID: 33121156 DOI: 10.3390/molecules25214977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
325 Zhang J, Li R, Liu Q, Zhou J, Huang H, Huang Y, Zhang Z, Wu T, Tang Q, Huang C, Zhao Y, Zhang G, Mo L, Li Y, He J. SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β Signaling. Mol Pharmaceutics 2020;17:4152-62. [DOI: 10.1021/acs.molpharmaceut.0c00633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
326 Cha JJ, Mandal C, Ghee JY, Yoo JA, Lee MJ, Kang YS, Hyun YY, Lee JE, Kim HW, Han SY, Han JY, Chung AY, Yoon DW, Rhyu IJ, Oh J, Cha DR. Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis. Biomedicines 2020;8:E431. [PMID: 33086608 DOI: 10.3390/biomedicines8100431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
327 de Oliveira CM, Martins LAM, de Sousa AC, Moraes KDS, Costa BP, Vieira MQ, Coelho BP, Borojevic R, de Oliveira JR, Guma FCR. Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells. Mol Cell Biochem 2021;476:649-61. [PMID: 33073314 DOI: 10.1007/s11010-020-03933-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
328 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
329 Voutilainen SH, Kosola SK, Lohi J, Mutka A, Jahnukainen T, Pakarinen M, Jalanko H. Expression of 6 Biomarkers in Liver Grafts After Pediatric Liver Transplantation: Correlations with Histology, Biochemistry, and Outcome. Ann Transplant 2020;25:e925980. [PMID: 33060556 DOI: 10.12659/AOT.925980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
330 Liao J, Zhang Z, Yuan Q, Liu Q, Kuang J, Fang Y, Hu X. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation. Toxicol Lett 2021;336:21-31. [PMID: 33069761 DOI: 10.1016/j.toxlet.2020.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
331 Rahman N, Kuramochi M, Izawa T, Kuwamura M, Yamate J. Characterization of Immature Myofibroblasts of Stellate Cell or Mesenchymal Cell Origin in D-Galactosamine-Induced Liver Injury in Rats. Vet Pathol 2021;58:80-90. [PMID: 33054583 DOI: 10.1177/0300985820963097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
332 Kremer A, VAN Hamme E, Bonnardel J, Borghgraef P, GuÉrin CJ, Guilliams M, Lippens S. A workflow for 3D-CLEM investigating liver tissue. J Microsc 2021;281:231-42. [PMID: 33034376 DOI: 10.1111/jmi.12967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
333 Wang S, Shuai C, Gao S, Jiang J, Luan J, Lv X. Chemokine CXCL14 acts as a potential genetic target for liver fibrosis. Int Immunopharmacol 2020;89:107067. [PMID: 33039963 DOI: 10.1016/j.intimp.2020.107067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
334 Güvendi GF, Eroğlu HA, Mustafa Makav, Güvendi B, Adalı Y. Selenium or ozone: Effects on liver injury caused by experimental iron overload. Life Sci 2020;262:118558. [PMID: 33038377 DOI: 10.1016/j.lfs.2020.118558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
335 Zhu J, Lu J, Tung HC, Liu K, Li J, Grant DM, Xie W, Ma X. Cell Type-Specific Roles of CD38 in the Interactions of Isoniazid with NAD+ in the Liver. Drug Metab Dispos 2020;48:1372-9. [PMID: 33020065 DOI: 10.1124/dmd.120.000139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
336 Molenaar MR, Penning LC, Helms JB. Playing Jekyll and Hyde-The Dual Role of Lipids in Fatty Liver Disease. Cells 2020;9:E2244. [PMID: 33036257 DOI: 10.3390/cells9102244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
337 Ma Y, Li Y, Zhang H, Wang Y, Wu C, Huang W. Malvidin induces hepatic stellate cell apoptosis via the endoplasmic reticulum stress pathway and mitochondrial pathway. Food Sci Nutr 2020;8:5095-106. [PMID: 32994970 DOI: 10.1002/fsn3.1810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
338 Han H, Desert R, Das S, Song Z, Athavale D, Ge X, Nieto N. Danger signals in liver injury and restoration of homeostasis. J Hepatol 2020;73:933-51. [PMID: 32371195 DOI: 10.1016/j.jhep.2020.04.033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
339 Gao Y, Li X, Gao Q, Fan L, Jin H, Guo Y. Differential effects of olive oil, soybean oil, corn oil and lard oil on carbon tetrachloride-induced liver fibrosis in mice. Biosci Rep 2019;39:BSR20191913. [PMID: 31481526 DOI: 10.1042/BSR20191913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
340 Kuchay MS, Choudhary NS, Mishra SK. Pathophysiological mechanisms underlying MAFLD. Diabetes Metab Syndr 2020;14:1875-87. [PMID: 32998095 DOI: 10.1016/j.dsx.2020.09.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
341 Kurniawan DW, Booijink R, Pater L, Wols I, Vrynas A, Storm G, Prakash J, Bansal R. Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo. J Control Release 2020;328:640-52. [PMID: 32979454 DOI: 10.1016/j.jconrel.2020.09.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
342 Zheng H, Yang Z, Xin Z, Yang Y, Yu Y, Cui J, Liu H, Chen F. Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis. Theranostics 2020;10:11737-53. [PMID: 33052244 DOI: 10.7150/thno.47717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
343 Dong HN, Park SY, Le CT, Choi DH, Cho EH. Irisin Regulates the Functions of Hepatic Stellate Cells. Endocrinol Metab (Seoul) 2020;35:647-55. [PMID: 32981307 DOI: 10.3803/EnM.2020.658] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
344 Wilson RB, Chen YJ, Sutherland BG, Sawyez CG, Zhang R, Woolnough T, Hetherington AM, Peters KM, Patel K, Kennelly JP, Leonard KA, Schuurman M, Jacobs RL, Wang R, Borradaile NM. The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease. Pharmacol Res 2020;161:105208. [PMID: 32977024 DOI: 10.1016/j.phrs.2020.105208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
345 Pesce A, Ciurleo R, Bramanti A, Armeli Iapichino EC, Petralia MC, Magro GG, Fagone P, Bramanti P, Nicoletti F, Mangano K. Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis. Molecules 2020;25:E4310. [PMID: 32962198 DOI: 10.3390/molecules25184310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
346 Azparren-Angulo M, Royo F, Gonzalez E, Liebana M, Brotons B, Berganza J, Goñi-de-Cerio F, Manicardi N, Abad-Jordà L, Gracia-Sancho J, Falcon-Perez JM. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacol Ther 2021;218:107683. [PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
347 Dobie R, Wilson-Kanamori JR, Henderson BEP, Smith JR, Matchett KP, Portman JR, Wallenborg K, Picelli S, Zagorska A, Pendem SV, Hudson TE, Wu MM, Budas GR, Breckenridge DG, Harrison EM, Mole DJ, Wigmore SJ, Ramachandran P, Ponting CP, Teichmann SA, Marioni JC, Henderson NC. Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis. Cell Rep 2019;29:1832-1847.e8. [PMID: 31722201 DOI: 10.1016/j.celrep.2019.10.024] [Cited by in Crossref: 142] [Cited by in F6Publishing: 118] [Article Influence: 47.3] [Reference Citation Analysis]
348 Xie Z, Wu Y, Liu S, Lai Y, Tang S. LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis. Clin Res Hepatol Gastroenterol 2021;45:101469. [PMID: 32893175 DOI: 10.1016/j.clinre.2020.05.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
349 Khodayari N, Oshins R, Holliday LS, Clark V, Xiao Q, Marek G, Mehrad B, Brantly M. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Commun Signal 2020;18:140. [PMID: 32887613 DOI: 10.1186/s12964-020-00648-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
350 Guan F, Zhang C, Jiang C, Jacques ML, Bai Y, Lu S, Liu W, Lei J. ApoE deficiency promotes hepatic pathology by aggravating Th17/Treg imbalance in murine schistosomiasis japonica. Parasite Immunol 2020;42:e12785. [PMID: 32786078 DOI: 10.1111/pim.12785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
351 Zhou G, Li C, Zhan Y, Zhang R, Lv B, Geng W, Zheng J. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway. Phytomedicine 2020;79:153321. [PMID: 32919323 DOI: 10.1016/j.phymed.2020.153321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
352 Job S, Rapoud D, Dos Santos A, Gonzalez P, Desterke C, Pascal G, Elarouci N, Ayadi M, Adam R, Azoulay D, Castaing D, Vibert E, Cherqui D, Samuel D, Sa Cuhna A, Marchio A, Pineau P, Guettier C, de Reyniès A, Faivre J. Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma. Hepatology 2020;72:965-81. [PMID: 31875970 DOI: 10.1002/hep.31092] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 31.0] [Reference Citation Analysis]
353 Nguyen PT, Kanno K, Pham QT, Kikuchi Y, Kakimoto M, Kobayashi T, Otani Y, Kishikawa N, Miyauchi M, Arihiro K, Ito M, Tazuma S. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma. J Cancer Res Clin Oncol 2020;146:3255-68. [PMID: 32870388 DOI: 10.1007/s00432-020-03374-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
354 Khadrawy SM, Mohamed HM, Mahmoud AM. Mesenchymal stem cells ameliorate oxidative stress, inflammation, and hepatic fibrosis via Nrf2/HO-1 signaling pathway in rats. Environ Sci Pollut Res Int 2021;28:2019-30. [PMID: 32865681 DOI: 10.1007/s11356-020-10637-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
355 Tuominen I, Fuqua BK, Pan C, Renaud N, Wroblewski K, Civelek M, Clerkin K, Asaryan A, Haroutunian SG, Loureiro J, Borawski J, Roma G, Knehr J, Carbone W, French S, Parks BW, Hui ST, Mehrabian M, Magyar C, Cantor RM, Ukomadu C, Lusis AJ, Beaven SW. The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Cell Mol Gastroenterol Hepatol 2021;11:199-220. [PMID: 32866618 DOI: 10.1016/j.jcmgh.2020.08.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
356 Boyer-Diaz Z, Morata P, Aristu-Zabalza P, Gibert-Ramos A, Bosch J, Gracia-Sancho J. Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical. Nutrients 2020;12:E2627. [PMID: 32872239 DOI: 10.3390/nu12092627] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
357 Guo YC, Lu LG. Antihepatic Fibrosis Drugs in Clinical Trials. J Clin Transl Hepatol 2020;8:304-12. [PMID: 33083254 DOI: 10.14218/JCTH.2020.00023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
358 Riaz F, Li D. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Curr Gene Ther 2019;19:305-17. [PMID: 31696817 DOI: 10.2174/1566523219666191107113046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
359 Häussinger D, Kordes C. Space of Disse: a stem cell niche in the liver. Biol Chem 2019;401:81-95. [PMID: 31318687 DOI: 10.1515/hsz-2019-0283] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
360 Hu N, Guo C, Dai X, Wang C, Gong L, Yu L, Peng C, Li Y. Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways. J Ethnopharmacol 2020;262:113275. [PMID: 32810620 DOI: 10.1016/j.jep.2020.113275] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
361 Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, Kirton KJ, Shah AP, Dang H. Hepatic Stellate Cells and Hepatocarcinogenesis. Front Cell Dev Biol 2020;8:709. [PMID: 32850829 DOI: 10.3389/fcell.2020.00709] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
362 Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol 2020;17:457-72. [PMID: 32483353 DOI: 10.1038/s41575-020-0304-x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 26.7] [Reference Citation Analysis]
363 Gupta V, Gupta I, Park J, Bram Y, Schwartz RE. Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells. Gastroenterology 2020;159:624-638.e9. [PMID: 32289375 DOI: 10.1053/j.gastro.2020.03.075] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
364 Yoshikawa E, Matsui-Yuasa I, Huang X, Kobayashi Y, Kojima-Yuasa A. Mallotus furetianus extract protects against ethanol-induced liver injury via the activation of the cAMP-PKA pathway. Food Sci Nutr 2020;8:3936-46. [PMID: 32724654 DOI: 10.1002/fsn3.1709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
365 Ibrahim SA, Mohamed MZ, El-Tahawy NF, Abdelrahman AM. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Can J Physiol Pharmacol 2021;99:313-20. [PMID: 32721217 DOI: 10.1139/cjpp-2020-0159] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
366 Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation. Circ Res 2020;127:427-47. [PMID: 32673537 DOI: 10.1161/CIRCRESAHA.120.316958] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 24.0] [Reference Citation Analysis]
367 George J, Tsuchishima M, Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (Berl) 2020;98:1203-13. [PMID: 32666246 DOI: 10.1007/s00109-020-01950-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
368 Masola V, Gambaro G, Onisto M. Impact of Heparanse on Organ Fibrosis. Adv Exp Med Biol 2020;1221:669-84. [PMID: 32274731 DOI: 10.1007/978-3-030-34521-1_27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
369 Li X, Shao S, Li H, Bi Z, Zhang S, Wei Y, Bai J, Zhang R, Ma X, Ma B, Zhang L, Xie C, Ning W, Zhou H, Yang C. Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice. J Cell Mol Med 2020;24:8623-35. [PMID: 32643868 DOI: 10.1111/jcmm.15493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
370 Roife D, Sarcar B, Fleming JB. Stellate Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1263:67-84. [PMID: 32588324 DOI: 10.1007/978-3-030-44518-8_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
371 Chen P, Luo X, Dai G, Jiang Y, Luo Y, Peng S, Wang H, Xie P, Qu C, Lin W, Hong J, Ning X, Li A. Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation. Exp Mol Med 2020;52:1062-74. [PMID: 32632241 DOI: 10.1038/s12276-020-0461-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
372 McVicker BL, Hamel FG, Simpson RL, Bennett RG. A Selective PPARγ Modulator Reduces Hepatic Fibrosis. Biology (Basel) 2020;9:E151. [PMID: 32630819 DOI: 10.3390/biology9070151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
373 Arab JP, Cabrera D, Sehrawat TS, Jalan-Sakrikar N, Verma VK, Simonetto D, Cao S, Yaqoob U, Leon J, Freire M, Vargas JI, De Assuncao TM, Kwon JH, Guo Y, Kostallari E, Cai Q, Kisseleva T, Oh Y, Arrese M, Huebert RC, Shah VH. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. J Hepatol 2020;73:149-60. [PMID: 32087348 DOI: 10.1016/j.jhep.2020.02.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
374 Villesen IF, Daniels SJ, Leeming DJ, Karsdal MA, Nielsen MJ. Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis. Aliment Pharmacol Ther 2020;52:85-97. [PMID: 32419162 DOI: 10.1111/apt.15773] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
375 Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, Suñer C, Bartrons R, Mendez R, Fernandez M. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis. Gastroenterology 2020;159:273-88. [PMID: 32169429 DOI: 10.1053/j.gastro.2020.03.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
376 Arriola Benitez PC, Pesce Viglietti AI, Elizalde MM, Giambartolomei GH, Quarleri JF, Delpino MV. Hepatic Stellate Cells and Hepatocytes as Liver Antigen-Presenting Cells during B. abortus Infection. Pathogens 2020;9:E527. [PMID: 32629846 DOI: 10.3390/pathogens9070527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
377 Ryou M, Stylopoulos N, Baffy G. Nonalcoholic fatty liver disease and portal hypertension. Explor Med 2020;1:149-69. [PMID: 32685936 DOI: 10.37349/emed.2020.00011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
378 Li H, Zhou Y, Wang H, Zhang M, Qiu P, Zhang M, Zhang R, Zhao Q, Liu J. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Front Immunol 2020;11:1169. [PMID: 32670278 DOI: 10.3389/fimmu.2020.01169] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
379 Chen Y, Fan Y, Guo DY, Xu B, Shi XY, Li JT, Duan LF. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother 2020;129:110413. [PMID: 32570119 DOI: 10.1016/j.biopha.2020.110413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
380 Hu N, Liu J, Xue X, Li Y. The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. Eur J Pharmacol 2020;882:173269. [PMID: 32553811 DOI: 10.1016/j.ejphar.2020.173269] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
381 Liang H, Li Z, Ren Z, Jia Q, Guo L, Li S, Zhang H, Hu S, Zhu D, Shen D, Yu Z, Cheng K. Light-triggered NO-releasing nanoparticles for treating mice with liver fibrosis. Nano Res 2020;13:2197-202. [DOI: 10.1007/s12274-020-2833-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
382 Bae M, Lee Y, Pham TX, Hu S, Park YK, Lee JY. Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells. Life Sci 2020;256:117926. [PMID: 32535081 DOI: 10.1016/j.lfs.2020.117926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
383 Widjaja AA, Chothani SP, Cook SA. Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy. Hum Vaccin Immunother 2020;16:2357-62. [PMID: 32530750 DOI: 10.1080/21645515.2020.1761203] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
384 Liu X, Mi X, Wang Z, Zhang M, Hou J, Jiang S, Wang Y, Chen C, Li W. Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis 2020;11:454. [PMID: 32532964 DOI: 10.1038/s41419-020-2597-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
385 Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M, Cannito S. Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 2020;689:108445. [PMID: 32524998 DOI: 10.1016/j.abb.2020.108445] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
386 Hernández A, Reyes D, Geng Y, Arab JP, Cabrera D, Sepulveda R, Solis N, Buist-Homan M, Arrese M, Moshage H. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells. Biochim Biophys Acta Mol Basis Dis 2020;1866:165857. [PMID: 32512191 DOI: 10.1016/j.bbadis.2020.165857] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
387 Yang X, Ma L, Wei R, Ye T, Zhou J, Wen M, Men R, Aqeilan RI, Peng Y, Yang L. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway. Signal Transduct Target Ther 2020;5:75. [PMID: 32499481 DOI: 10.1038/s41392-020-0169-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
388 Thuy LTT, Hai H, Kawada N. Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis. Clin Mol Hepatol 2020;26:280-93. [PMID: 32492766 DOI: 10.3350/cmh.2020.0037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
389 Zhang M, Wang Y, Zhu G, Sun C, Wang J. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice. Naunyn Schmiedebergs Arch Pharmacol 2021;394:189-204. [PMID: 32474674 DOI: 10.1007/s00210-020-01891-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
390 Alevra Sarika N, Payen VL, Fléron M, Ravau J, Brusa D, Najimi M, Pauw E, Eppe G, Mazzucchelli G, Sokal EM, Rieux AD, Taghdouini AE. Human Liver-Derived Extracellular Matrix for the Culture of Distinct Human Primary Liver Cells. Cells 2020;9:E1357. [PMID: 32486126 DOI: 10.3390/cells9061357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
391 de Gregorio E, Colell A, Morales A, Marí M. Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. Int J Mol Sci 2020;21:E3858. [PMID: 32485811 DOI: 10.3390/ijms21113858] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
392 Nishimoto K, Toya Y, Davis CR, Tanumihardjo SA, Welham NV. Dynamics of vitamin A uptake, storage, and utilization in vocal fold mucosa. Mol Metab 2020;40:101025. [PMID: 32473404 DOI: 10.1016/j.molmet.2020.101025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Brovold M, Keller D, Soker S. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnol Bioeng 2020;117:2516-26. [PMID: 32391915 DOI: 10.1002/bit.27379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
394 He L, Yuan H, Liang J, Hong J, Qu C. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis. PLoS One 2020;15:e0233702. [PMID: 32442221 DOI: 10.1371/journal.pone.0233702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
395 Yang YL, Wang FS, Lin HY, Huang YH. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha. Int J Mol Sci 2020;21:E3636. [PMID: 32455716 DOI: 10.3390/ijms21103636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
396 Cao Q, Lu X, Azad BB, Pomper M, Smith M, He J, Pi L, Ren B, Ying Z, Sichani BS, Morris M, Dilsizian V. cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis. Front Mol Biosci 2020;7:90. [PMID: 32500081 DOI: 10.3389/fmolb.2020.00090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
397 Dong Z, Li S, Si L, Ma R, Bao L, Bo A. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis. Eur J Clin Invest 2020;50:e13243. [PMID: 32306379 DOI: 10.1111/eci.13243] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
398 An P, Wei LL, Zhao S, Sverdlov DY, Vaid KA, Miyamoto M, Kuramitsu K, Lai M, Popov YV. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun 2020;11:2362. [PMID: 32398673 DOI: 10.1038/s41467-020-16092-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 23.7] [Reference Citation Analysis]
399 Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G, Laccabue D, Zecca A, Penna A, Missale G, Ferrari C, Boni C. Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches. Front Immunol. 2020;11:849. [PMID: 32477347 DOI: 10.3389/fimmu.2020.00849] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
400 Liu Q, Liu Q, Lei X, Cao Z, Zhang J, Kuang T, Liu G, Fang Y, Qian K, Fu J, Du H, Yan L, Xiao Z, Li C, Xu X. Protective effect of oil from Cornus wilsoniana fruits against carbon tetrachloride-induced hepatic fibrosis in mice. Food & Nutrition Research 2020;64. [DOI: 10.29219/fnr.v64.4205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
401 Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(17): 1993-2011 [PMID: 32536770 DOI: 10.3748/wjg.v26.i17.1993] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 43] [Article Influence: 14.3] [Reference Citation Analysis]
402 Khalil MR, El-Demerdash RS, Elminshawy HH, Mehanna ET, Mesbah NM, Abo-Elmatty DM. Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. Biomed J. 2020. [PMID: 32389821 DOI: 10.1016/j.bj.2020.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
403 Li F, Huangyang P, Burrows M, Guo K, Riscal R, Godfrey J, Lee KE, Lin N, Lee P, Blair IA, Keith B, Li B, Simon MC. FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat Cell Biol 2020;22:728-39. [PMID: 32367049 DOI: 10.1038/s41556-020-0511-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 18.7] [Reference Citation Analysis]
404 Wagner C, Hois V, Pajed L, Pusch LM, Wolinski H, Trauner M, Zimmermann R, Taschler U, Lass A. Lysosomal acid lipase is the major acid retinyl ester hydrolase in cultured human hepatic stellate cells but not essential for retinyl ester degradation. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158730. [PMID: 32361002 DOI: 10.1016/j.bbalip.2020.158730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
405 Mantovani A, Taliento A, Zusi C, Baselli G, Prati D, Granata S, Zaza G, Colecchia A, Maffeis C, Byrne CD, Valenti L, Targher G. PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings. Liver Int 2020;40:1130-41. [PMID: 32125756 DOI: 10.1111/liv.14419] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
406 Schwabe RF, Tabas I, Pajvani UB. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology 2020;158:1913-28. [PMID: 32044315 DOI: 10.1053/j.gastro.2019.11.311] [Cited by in Crossref: 164] [Cited by in F6Publishing: 160] [Article Influence: 54.7] [Reference Citation Analysis]
407 Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era? Front Pharmacol 2020;11:548. [PMID: 32425789 DOI: 10.3389/fphar.2020.00548] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
408 Kundu A, Dey P, Park JH, Kim IS, Kwack SJ, Kim HS. EX-527 Prevents the Progression of High-Fat Diet-Induced Hepatic Steatosis and Fibrosis by Upregulating SIRT4 in Zucker Rats. Cells 2020;9:E1101. [PMID: 32365537 DOI: 10.3390/cells9051101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
409 Fathy M, Okabe M, M Othman E, Saad Eldien HM, Yoshida T. Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis. Molecules 2020;25:E2020. [PMID: 32357508 DOI: 10.3390/molecules25092020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
410 Rossato M, Di Vincenzo A, Pagano C, El Hadi H, Vettor R. The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. Cells 2020;9:E1047. [PMID: 32331389 DOI: 10.3390/cells9041047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
411 Zhou D, Huang W, Wei J, Zhang J, Liu Z, Ji R, Ge S, Xiao M, Fan Y, Lu C. RelB promotes liver fibrosis via inducing the release of injury-associated inflammatory cytokines. J Cell Mol Med 2020;24:6008-14. [PMID: 32306539 DOI: 10.1111/jcmm.15108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
412 Kukla DA, Crampton AL, Wood DK, Khetani SR. Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in Three-Dimensional Models. Gene Expr 2020;20:1-18. [PMID: 32290899 DOI: 10.3727/105221620X15868728381608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
413 Gupta B, Liu Y, Chopyk DM, Rai RP, Desai C, Kumar P, Farris AB, Nusrat A, Parkos CA, Anania FA, Raeman R. Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. FASEB J 2020;34:7089-102. [PMID: 32275114 DOI: 10.1096/fj.201902687R] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
414 Bhushan B, Michalopoulos GK. Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor. Chem Biol Interact 2020;324:109090. [PMID: 32283070 DOI: 10.1016/j.cbi.2020.109090] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
415 Cotovio JP, Fernandes TG. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. Bioengineering (Basel) 2020;7:E36. [PMID: 32283585 DOI: 10.3390/bioengineering7020036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
416 Huang C, Ogawa R. The Vascular Involvement in Soft Tissue Fibrosis-Lessons Learned from Pathological Scarring. Int J Mol Sci 2020;21:E2542. [PMID: 32268503 DOI: 10.3390/ijms21072542] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
417 Gu L, Yu T, Liu J, Lu Y. Evaluation of the mechanism of cordyceps polysaccharide action on rat acute liver failure. Arch Med Sci 2020;16:1218-25. [PMID: 32864011 DOI: 10.5114/aoms.2020.94236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
418 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 198] [Cited by in F6Publishing: 218] [Article Influence: 66.0] [Reference Citation Analysis]
419 Xiong X, Kuang H, Liu T, Lin JD. A Single-Cell Perspective of the Mammalian Liver in Health and Disease. Hepatology 2020;71:1467-73. [PMID: 31997380 DOI: 10.1002/hep.31149] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
420 Lin L, Gong H, Li R, Huang J, Cai M, Lan T, Huang W, Guo Y, Zhou Z, An Y, Chen Z, Liang L, Wang Y, Shuai X, Zhu K. Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation. Adv Sci (Weinh) 2020;7:1903138. [PMID: 32274310 DOI: 10.1002/advs.201903138] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
421 Zirnis AE, Straume Z, Bērziņa R, Māliņa-bambīte J, Derovs A, Zeltiņa I. Establishing Cut-Offs for Non-Invasive Liver Tests to Detect Cirrhosis at a High Sensitivity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020;74:118-124. [DOI: 10.2478/prolas-2020-0019] [Reference Citation Analysis]
422 Li W, Zhou C, Fu Y, Chen T, Liu X, Zhang Z, Gong T. Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats. Acta Pharm Sin B 2020;10:693-710. [PMID: 32322471 DOI: 10.1016/j.apsb.2019.07.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
423 Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based treatments of complications of cirrhosis. Scand J Gastroenterol 2020;55:383-94. [PMID: 32233873 DOI: 10.1080/00365521.2020.1744709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
424 Sällberg M, Pasetto A. Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation. Front Immunol 2020;11:552. [PMID: 32292409 DOI: 10.3389/fimmu.2020.00552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
425 Hernández A, Arab JP, Reyes D, Lapitz A, Moshage H, Bañales JM, Arrese M. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy. Cells 2020;9:E817. [PMID: 32231001 DOI: 10.3390/cells9040817] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
426 Abo-Zaid MA, Shaheen ES, Ismail AH. Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats. J Food Biochem 2020;44:e13219. [PMID: 32215945 DOI: 10.1111/jfbc.13219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
427 Gerhard GS, Davis B, Wu X, Hanson A, Wilhelmsen D, Piras IS, Still CD, Chu X, Petrick AT, DiStefano JK. Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis. Biochem Biophys Rep 2020;22:100753. [PMID: 32258441 DOI: 10.1016/j.bbrep.2020.100753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
428 van Dijk F, Hazelhoff CM, Post E, Prins GGH, Rombouts K, Poelstra K, Olinga P, Beljaars L. Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis. Pharmaceutics 2020;12:E278. [PMID: 32244897 DOI: 10.3390/pharmaceutics12030278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
429 He X, Chen J, Mu Y, Zhang H, Chen G, Liu P, Liu W. The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol. J Nat Med 2020;74:513-24. [PMID: 32193805 DOI: 10.1007/s11418-020-01394-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
430 Boey A, Ho HK. All Roads Lead to the Liver: Metal Nanoparticles and Their Implications for Liver Health. Small 2020;16:2000153. [DOI: 10.1002/smll.202000153] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
431 Sakaguchi T, Kono Y, Itaba N, Morimoto M, Isomoto H, Shiota G. Identification of a Novel Deactivating Small-Molecule Compound for Fibrogenic Hepatic Stellate Cells. Yonago Acta Med 2020;63:79-87. [PMID: 32158337 DOI: 10.33160/yam.2020.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
432 Ruan Q, Wang H, Burke LJ, Bridle KR, Li X, Zhao CX, Crawford DHG, Roberts MS, Liang X. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma. Int J Cancer 2020;147:1519-27. [PMID: 32010970 DOI: 10.1002/ijc.32899] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
433 Overi D, Carpino G, Franchitto A, Onori P, Gaudio E. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis. Cells 2020;9:E590. [PMID: 32131439 DOI: 10.3390/cells9030590] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
434 Hoffmann C, Djerir NEH, Danckaert A, Fernandes J, Roux P, Charrueau C, Lachagès AM, Charlotte F, Brocheriou I, Clément K, Aron-Wisnewsky J, Foufelle F, Ratziu V, Hainque B, Bonnefont-Rousselot D, Bigey P, Escriou V. Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis. Sci Rep 2020;10:3850. [PMID: 32123215 DOI: 10.1038/s41598-020-60615-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
435 Shi Z, Ren M, Rockey DC. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis. Am J Physiol Gastrointest Liver Physiol 2020;318:G504-17. [PMID: 31928221 DOI: 10.1152/ajpgi.00302.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
436 Saberi-karimian M, Keshvari M, Ghayour-mobarhan M, Salehizadeh L, Rahmani S, Behnam B, Jamialahmadi T, Asgary S, Sahebkar A. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complementary Therapies in Medicine 2020;49:102322. [DOI: 10.1016/j.ctim.2020.102322] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 14.7] [Reference Citation Analysis]
437 Lee DY, Yun SM, Song MY, Ji SD, Son JG, Kim EH. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats. Cells 2020;9:E568. [PMID: 32121064 DOI: 10.3390/cells9030568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
438 Xu X, Yu H, Sun L, Zheng C, Shan Y, Zhou Z, Wang C, Chen B. Adipose‑derived mesenchymal stem cells ameliorate dibutyltin dichloride‑induced chronic pancreatitis by inhibiting the PI3K/AKT/mTOR signaling pathway. Mol Med Rep 2020;21:1833-40. [PMID: 32319628 DOI: 10.3892/mmr.2020.10995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
439 Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 2020;155:104720. [PMID: 32092405 DOI: 10.1016/j.phrs.2020.104720] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 15.0] [Reference Citation Analysis]
440 Navarro-Corcuera A, Ansorena E, Montiel-Duarte C, Iraburu MJ. AGAP2: Modulating TGFβ1-Signaling in the Regulation of Liver Fibrosis. Int J Mol Sci 2020;21:E1400. [PMID: 32092977 DOI: 10.3390/ijms21041400] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
441 Buniatian GH, Weiskirchen R, Weiss TS, Schwinghammer U, Fritz M, Seferyan T, Proksch B, Glaser M, Lourhmati A, Buadze M, Borkham-Kamphorst E, Gaunitz F, Gleiter CH, Lang T, Schaeffeler E, Tremmel R, Cynis H, Frey WH 2nd, Gebhardt R, Friedman SL, Mikulits W, Schwab M, Danielyan L. Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells 2020;9:E452. [PMID: 32089540 DOI: 10.3390/cells9020452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
442 Miyazoe Y, Miuma S, Miyaaki H, Kanda Y, Nakashiki S, Sasaki R, Haraguchi M, Shibata H, Honda T, Taura N, Nakao K. Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells. Biomed Rep 2020;12:163-70. [PMID: 32190304 DOI: 10.3892/br.2020.1279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
443 Lee YA, Friedman SL. Stellate Cells and Fibrosis. The Liver 2020. [DOI: 10.1002/9781119436812.ch36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
444 Alolga RN, Nuer-allornuvor GF, Kuugbee ED, Yin X, Ma G. Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: A review of scientific findings and call for further research. Pharmacological Research 2020;152:104630. [DOI: 10.1016/j.phrs.2020.104630] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
445 Zhang T, Hao H, Zhou Z, Zeng T, Zhang J, Zhou X. Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway. Prostaglandins & Other Lipid Mediators 2020;146:106380. [DOI: 10.1016/j.prostaglandins.2019.106380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
446 Elbadawy M, Yamanaka M, Goto Y, Hayashi K, Tsunedomi R, Hazama S, Nagano H, Yoshida T, Shibutani M, Ichikawa R, Nakahara J, Omatsu T, Mizutani T, Katayama Y, Shinohara Y, Abugomaa A, Kaneda M, Yamawaki H, Usui T, Sasaki K. Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model. Biomaterials 2020;237:119823. [PMID: 32044522 DOI: 10.1016/j.biomaterials.2020.119823] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
447 Das D, Fayazzadeh E, Li X, Koirala N, Wadera A, Lang M, Zernic M, Panick C, Nesbitt P, McLennan G. Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase-independent cell death pathway: Central role of apoptosis-inducing factor. J Cell Physiol 2020;235:6167-82. [PMID: 31975386 DOI: 10.1002/jcp.29545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
448 Jarman EJ, Boulter L. Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair. Expert Opinion on Investigational Drugs 2020;29:179-90. [DOI: 10.1080/13543784.2020.1718105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
449 Kim JY, Kim KM, Yang JH, Cho SS, Kim SJ, Park SJ, Ahn SG, Lee GH, Yang JW, Lim SC, Kang KW, Ki SH. Induction of E6AP by microRNA-302c dysregulation inhibits TGF-β-dependent fibrogenesis in hepatic stellate cells. Sci Rep 2020;10:444. [PMID: 31949242 DOI: 10.1038/s41598-019-57322-w] [Reference Citation Analysis]
450 Kim JY, Kim KM, Yang JH, Cho SS, Kim SJ, Park SJ, Ahn SG, Lee GH, Yang JW, Lim SC, Kang KW, Ki SH. Induction of E6AP by microRNA-302c dysregulation inhibits TGF-β-dependent fibrogenesis in hepatic stellate cells. Sci Rep 2020;10:444. [PMID: 31949242 DOI: 10.1038/s41598-019-57322-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
451 Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, Zhao XY, Ji Y, Li C, Guo L, Zhou L, Chen Z, Leon-Mimila P, Chung MT, Kurabayashi K, Opp J, Campos-Pérez F, Villamil-Ramírez H, Canizales-Quinteros S, Lyons R, Lumeng CN, Zhou B, Qi L, Huertas-Vazquez A, Lusis AJ, Xu XZS, Li S, Yu Y, Li JZ, Lin JD. Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. Mol Cell 2019;75:644-660.e5. [PMID: 31398325 DOI: 10.1016/j.molcel.2019.07.028] [Cited by in Crossref: 286] [Cited by in F6Publishing: 302] [Article Influence: 95.3] [Reference Citation Analysis]
452 Fathy M, Okabe M, Saad Eldien HM, Yoshida T. AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats. Molecules 2020;25:E348. [PMID: 31952158 DOI: 10.3390/molecules25020348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
453 Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol 2020; 26(2): 109-133 [PMID: 31969775 DOI: 10.3748/wjg.v26.i2.109] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 61] [Article Influence: 20.7] [Reference Citation Analysis]
454 Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 2020;245:96-108. [PMID: 31924111 DOI: 10.1177/1535370219898141] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 19.0] [Reference Citation Analysis]
455 Sha M, Gao Y, Deng C, Wan Y, Zhuang Y, Hu X, Wang Y. Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice. Int Immunopharmacol 2020;79:106157. [PMID: 31911372 DOI: 10.1016/j.intimp.2019.106157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
456 Segal-Salto M, Barashi N, Katav A, Edelshtein V, Aharon A, Hashmueli S, George J, Maor Y, Pinzani M, Haberman D, Hall A, Friedman S, Mor A. A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage. JHEP Rep 2020;2:100064. [PMID: 32039405 DOI: 10.1016/j.jhepr.2019.100064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
457 Cichocki JA. Target sites: liver. Information Resources in Toxicology 2020. [DOI: 10.1016/b978-0-12-813724-6.00057-8] [Reference Citation Analysis]
458 Arthanari S, Periyasamy P. Phenolic composition, antioxidant and anti-fibrotic effects of Sesbania grandiflora L. (Agastya) – An edible medicinal plant. AYU 2020;41:242. [DOI: 10.4103/ayu.ayu_198_19] [Reference Citation Analysis]
459 Romeo S, Sanyal A, Valenti L. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease. Cell Metabolism 2020;31:35-45. [DOI: 10.1016/j.cmet.2019.12.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 28.3] [Reference Citation Analysis]
460 Gnecchi M, Ciuffreda MC, Mura M. Mesenchymal Stromal Cell Secretome for Tissue Repair. Cell Engineering and Regeneration 2020. [DOI: 10.1007/978-3-319-08831-0_43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
461 Ельчанинов АВ, Фатхудинов ТХ. Регенерация печени млекопитающих: межклеточные взаимодействия. 2020. [DOI: 10.7868/9785020407770] [Reference Citation Analysis]
462 Basson R, Bayat A. Fibrosis and diabetes: Chronic hyperglycemia triggers organ-specific fibrotic mechanisms. Wound Healing, Tissue Repair, and Regeneration in Diabetes 2020. [DOI: 10.1016/b978-0-12-816413-6.00007-1] [Reference Citation Analysis]
463 Ishida S. Requirements for designing organ-on-a-chip platforms to model the pathogenesis of liver disease. Organ-on-a-chip 2020. [DOI: 10.1016/b978-0-12-817202-5.00005-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
464 Jia Z, Zhao C, Wang M, Zhao X, Zhang W, Han T, Xia Q, Han Z, Lin R, Li X. Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome. Biomedicine & Pharmacotherapy 2020;121:109558. [DOI: 10.1016/j.biopha.2019.109558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
465 Pastore M, Gentilini A, Marra F. Mechanisms of Fibrogenesis in NASH. Non-Alcoholic Fatty Liver Disease 2020. [DOI: 10.1007/978-3-319-95828-6_6] [Reference Citation Analysis]
466 Guillot A, Gao B. Immunopathogenesis of Liver Cirrhosis. Liver Immunology 2020. [DOI: 10.1007/978-3-030-51709-0_35] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
467 Chen T, Lin H, Chen X, Li G, Zhao Y, Zheng L, Shi Z, Zhang K, Hong W, Han T. LncRNA Meg8 suppresses activation of hepatic stellate cells and epithelial-mesenchymal transition of hepatocytes via the Notch pathway. Biochemical and Biophysical Research Communications 2020;521:921-7. [DOI: 10.1016/j.bbrc.2019.11.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
468 Carotti S, Morini S, Carpino G, Gaudio E. Liver Histology. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_2] [Reference Citation Analysis]
469 Safaei A, Arefi Oskouie A, Mohebbi SR, Razaghi Z, Nejadi N. Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers. Gastroenterol Hepatol Bed Bench 2020;13:S113-21. [PMID: 33585012] [Reference Citation Analysis]
470 Polvani S, Pepe S, Milani S, Galli A. COUP-TFII in Health and Disease. Cells 2019;9:E101. [PMID: 31906104 DOI: 10.3390/cells9010101] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
471 Bravo M, Raurell I, Hide D, Fernández-Iglesias A, Gil M, Barberá A, Salcedo MT, Augustin S, Genescà J, Martell M. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH. Sci Rep 2019;9:20183. [PMID: 31882668 DOI: 10.1038/s41598-019-56366-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
472 Zhang R, Gao X, Zuo J, Hu B, Yang J, Zhao J, Chen J. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci 2020;111:406-17. [PMID: 31785057 DOI: 10.1111/cas.14262] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
473 Winkler I, Bitter C, Winkler S, Weichenhan D, Thavamani A, Hengstler JG, Borkham-Kamphorst E, Kohlbacher O, Plass C, Geffers R, Weiskirchen R, Nordheim A. Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment. Proc Natl Acad Sci U S A 2020;117:454-63. [PMID: 31871210 DOI: 10.1073/pnas.1909145117] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
474 Ure DR, Trepanier DJ, Mayo PR, Foster RT. Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs 2020;29:163-78. [DOI: 10.1080/13543784.2020.1703948] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
475 Khomich O, Ivanov AV, Bartosch B. Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells 2019;9:E24. [PMID: 31861818 DOI: 10.3390/cells9010024] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 15.8] [Reference Citation Analysis]
476 Akbari S, Arslan N, Senturk S, Erdal E. Next-Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol 2019;7:345. [PMID: 31921856 DOI: 10.3389/fcell.2019.00345] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
477 Giambartolomei GH, Delpino MV. Immunopathogenesis of Hepatic Brucellosis. Front Cell Infect Microbiol 2019;9:423. [PMID: 31956605 DOI: 10.3389/fcimb.2019.00423] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
478 Park YJ, Kim DM, Jeong MH, Yu JS, So HM, Bang IJ, Kim HR, Kwon SH, Kim KH, Chung KH. (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway. Cells 2019;9:E30. [PMID: 31861943 DOI: 10.3390/cells9010030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
479 Mahmoud AM, Hozayen WG, Hasan IH, Shaban E, Bin-Jumah M. Umbelliferone Ameliorates CCl4-Induced Liver Fibrosis in Rats by Upregulating PPARγ and Attenuating Oxidative Stress, Inflammation, and TGF-β1/Smad3 Signaling. Inflammation 2019;42:1103-16. [PMID: 30741365 DOI: 10.1007/s10753-019-00973-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
480 Valentino G, Zivko C, Weber F, Brülisauer L, Luciani P. Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics 2019;11:E676. [PMID: 31842373 DOI: 10.3390/pharmaceutics11120676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
481 Ramirez-Pedraza M, Fernández M. Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease. Front Immunol 2019;10:2882. [PMID: 31921146 DOI: 10.3389/fimmu.2019.02882] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
482 Kim JK, Han NR, Park SM, Jegal KH, Jung JY, Jung EH, Kim EO, Kim D, Jung DH, Lee JR, Park CA, Ku SK, Cho IJ, Kim SC. Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt. Food Chem Toxicol 2020;135:111044. [PMID: 31830547 DOI: 10.1016/j.fct.2019.111044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
483 Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S. Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults. Nutrients 2019;11:E3008. [PMID: 31835303 DOI: 10.3390/nu11123008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
484 Lachiondo-Ortega S, Mercado-Gómez M, Serrano-Maciá M, Lopitz-Otsoa F, Salas-Villalobos TB, Varela-Rey M, Delgado TC, Martínez-Chantar ML. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells 2019;8:E1575. [PMID: 31817258 DOI: 10.3390/cells8121575] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
485 Kow AWC. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol 2019;10:1274-98. [PMID: 31949948 DOI: 10.21037/jgo.2019.08.06] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 13.0] [Reference Citation Analysis]
486 He Q, Xia X, Yao K, Zeng J, Wang W, Wu Q, Tang R, Zou X. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. Life Sciences 2019;239:117010. [DOI: 10.1016/j.lfs.2019.117010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
487 Mahmoud MG, Asker MS, El Awady ME, Hassan AI, Zaharan NAR, Youssef HF. Effect of nanopolysaccharide (BSEPS) from Bacillus subtilis sp. on thioacetamide-induced liver fibrosis in rats. Bull Natl Res Cent 2019;43:184. [DOI: 10.1186/s42269-019-0244-1] [Reference Citation Analysis]
488 Kukla DA, Crampton AL, Wood DK, Khetani SR. Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in 3-Dimensional Models.. [DOI: 10.1101/857789] [Reference Citation Analysis]
489 Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia. Circulation 2020;141:67-79. [PMID: 31779484 DOI: 10.1161/CIRCULATIONAHA.119.042476] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 14.8] [Reference Citation Analysis]
490 Furukawa S, Yamaguchi M, Ooka A, Kikuchi H, Ishikawa T, Saito SY. Differentiation-inducing factor-1 prevents hepatic stellate cell activation through inhibiting GSK3β inactivation. Biochem Biophys Res Commun 2019;520:140-4. [PMID: 31582219 DOI: 10.1016/j.bbrc.2019.09.117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
491 Hintermann E, Christen U. The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis. Cells 2019;8:E1503. [PMID: 31771248 DOI: 10.3390/cells8121503] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
492 Eubanks HB, Lavoie EG, Goree J, Kamykowski JA, Gokden N, Fausther M, Dranoff JA. Reduction in SNAP-23 Alters Microfilament Organization in Myofibrobastic Hepatic Stellate Cells. Gene Expr 2020;20:25-37. [PMID: 31757226 DOI: 10.3727/105221619X15742818049365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
493 Liu W, Feng R, Li X, Li D, Zhai W. TGF-β- and lipopolysaccharide-induced upregulation of circular RNA PWWP2A promotes hepatic fibrosis via sponging miR-203 and miR-223. Aging (Albany NY) 2019;11:9569-80. [PMID: 31719209 DOI: 10.18632/aging.102405] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
494 Chang ML, Yang SS. Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology. Cells 2019;8:E1423. [PMID: 31726658 DOI: 10.3390/cells8111423] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
495 Wu Y, Li Z, Wang S, Xiu A, Zhang C. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway. Biomed Res Int 2019;2019:7932046. [PMID: 31828132 DOI: 10.1155/2019/7932046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
496 Modak RV, Zaiss DM. Isolation and Culture of Murine Hepatic Stellate Cells. Bio Protoc 2019;9:e3422. [PMID: 31993460 DOI: 10.21769/BioProtoc.3422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
497 Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L, Peng C, Li Y. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. J Ethnopharmacol 2020;248:112361. [PMID: 31683033 DOI: 10.1016/j.jep.2019.112361] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
498 Devarasetty M, Dominijanni A, Herberg S, Shelkey E, Skardal A, Soker S. Simulating the human tumor microenvironment in colorectal cancer organoids in vitro and in vivo.. [DOI: 10.1101/822684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
499 Wang S, Yu J, Kane MA, Moise AR. Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair. Pharmacol Ther 2020;205:107415. [PMID: 31629008 DOI: 10.1016/j.pharmthera.2019.107415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
500 Fernando DH, Forbes JM, Angus PW, Herath CB. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. Int J Mol Sci. 2019;20. [PMID: 31614491 DOI: 10.3390/ijms20205037] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
501 Rajapaksha IG, Gunarathne LS, Asadi K, Cunningham SC, Sharland A, Alexander IE, Angus PW, Herath CB. Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice. Hepatol Commun. 2019;3:1656-1673. [PMID: 31832573 DOI: 10.1002/hep4.1434] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
502 Schmidt-Arras D, Rose-John S. Regulation of Fibrotic Processes in the Liver by ADAM Proteases. Cells 2019;8:E1226. [PMID: 31601007 DOI: 10.3390/cells8101226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
503 Pibiri M. Liver regeneration in aged mice: new insights. Aging (Albany NY) 2018;10:1801-24. [PMID: 30157472 DOI: 10.18632/aging.101524] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
504 Geng W, Zhou G, Zhao B, Xiao Q, Li C, Fan S, Dong P, Zheng J. Liquiritigenin suppresses the activation of hepatic stellate cells via targeting miR-181b/PTEN axis. Phytomedicine 2020;66:153108. [PMID: 31790896 DOI: 10.1016/j.phymed.2019.153108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
505 Zhang AH, Jiang N, Wang XQ, Tan RX. Galewone, an Anti-Fibrotic Polyketide from Daldinia eschscholzii with an Undescribed Carbon Skeleton. Sci Rep 2019;9:14316. [PMID: 31586120 DOI: 10.1038/s41598-019-50868-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
506 Delogu W, Caligiuri A, Provenzano A, Rosso C, Bugianesi E, Coratti A, Macias-Barragan J, Galastri S, Di Maira G, Marra F. Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation. Dig Liver Dis 2019;51:1400-8. [PMID: 31005555 DOI: 10.1016/j.dld.2019.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
507 Ng WL, Chua CK, Shen Y. Print Me An Organ! Why We Are Not There Yet. Progress in Polymer Science 2019;97:101145. [DOI: 10.1016/j.progpolymsci.2019.101145] [Cited by in Crossref: 129] [Cited by in F6Publishing: 79] [Article Influence: 32.3] [Reference Citation Analysis]
508 Wang S, Kim J, Lee C, Oh D, Han J, Kim T, Kim S, Seo Y, Oh S, Jung Y. Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse. Biomaterials 2019;219:119375. [DOI: 10.1016/j.biomaterials.2019.119375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
509 Velázquez-Miranda E, Díaz-Muñoz M, Vázquez-Cuevas FG. Purinergic signaling in hepatic disease. Purinergic Signal 2019;15:477-89. [PMID: 31576486 DOI: 10.1007/s11302-019-09680-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
510 Bonnardel J, T'Jonck W, Gaublomme D, Browaeys R, Scott CL, Martens L, Vanneste B, De Prijck S, Nedospasov SA, Kremer A, Van Hamme E, Borghgraef P, Toussaint W, De Bleser P, Mannaerts I, Beschin A, van Grunsven LA, Lambrecht BN, Taghon T, Lippens S, Elewaut D, Saeys Y, Guilliams M. Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche. Immunity 2019;51:638-654.e9. [PMID: 31561945 DOI: 10.1016/j.immuni.2019.08.017] [Cited by in Crossref: 231] [Cited by in F6Publishing: 238] [Article Influence: 57.8] [Reference Citation Analysis]
511 Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
512 Kosakai T, Kato H, Sho C, Kawano K, Iwai KI, Takase Y, Ogawa K, Nishiyama K, Yamasaki M. Dietary fermented products using koji mold and sweet potato-shochu distillery by-product promotes hepatic and serum cholesterol levels and modulates gut microbiota in mice fed a high-cholesterol diet. PeerJ 2019;7:e7671. [PMID: 31565580 DOI: 10.7717/peerj.7671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
513 Jiang L, Yang M, Li X, Wang Y, Zhou G, Zhao J. CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte-Stellate Cell Crosstalk. J Clin Endocrinol Metab 2018;103:3974-85. [PMID: 30053055 DOI: 10.1210/jc.2018-00762] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
514 Dai X, Chen C, Xue J, Xiao T, Mostofa G, Wang D, Chen X, Xu H, Sun Q, Li J, Wei Y, Chen F, Quamruzzaman Q, Zhang A, Liu Q. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite. Toxicol Lett 2019;316:73-84. [PMID: 31513886 DOI: 10.1016/j.toxlet.2019.09.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
515 Smirne C, Rigamonti C, De Benedittis C, Sainaghi PP, Bellan M, Burlone ME, Castello LM, Avanzi GC. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. Dis Markers 2019;2019:2304931. [PMID: 31583026 DOI: 10.1155/2019/2304931] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
516 Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849 [PMID: 31543677 DOI: 10.3748/wjg.v25.i33.4835] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
517 Elchaninov AV, Fatkhudinov TK, Vishnyakova PA, Lokhonina AV, Sukhikh GT. Phenotypical and Functional Polymorphism of Liver Resident Macrophages. Cells 2019;8:E1032. [PMID: 31491903 DOI: 10.3390/cells8091032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
518 Zhai X, Wang W, Dou D, Ma Y, Gang D, Jiang Z, Shi B, Jin B. A novel technique to prepare a single cell suspension of isolated quiescent human hepatic stellate cells. Sci Rep 2019;9:12757. [PMID: 31485000 DOI: 10.1038/s41598-019-49287-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
519 Moscoso CG, Steer CJ. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics. Hepat Med 2019;11:109-29. [PMID: 31565001 DOI: 10.2147/HMER.S213397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
520 Widjaja AA, Singh BK, Adami E, Viswanathan S, Dong J, D'Agostino GA, Ng B, Lim WW, Tan J, Paleja BS, Tripathi M, Lim SY, Shekeran SG, Chothani SP, Rabes A, Sombetzki M, Bruinstroop E, Min LP, Sinha RA, Albani S, Yen PM, Schafer S, Cook SA. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Gastroenterology 2019;157:777-792.e14. [PMID: 31078624 DOI: 10.1053/j.gastro.2019.05.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 30.3] [Reference Citation Analysis]
521 Tang S, Li Y, Bao Y, Dai Z, Niu T, Wang K, He H, Song D. Novel cytisine derivatives exert anti-liver fibrosis effect via PI3K/Akt/Smad pathway. Bioorganic Chemistry 2019;90:103032. [DOI: 10.1016/j.bioorg.2019.103032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
522 Mohamed RH, Tarek M, Hamam GG, Ezzat SF. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis. European Journal of Pharmacology 2019;858:172469. [DOI: 10.1016/j.ejphar.2019.172469] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
523 Park JH, Kim J, Choi S, Cha K, Park H, Lee J, Lee B, Moon JW, Park S, Lee JM, Lee HS, Oh J. Albumin inhibits the activation of hepatic stellate cells by suppressing TGF-β/Smad3 signaling via IL-1β.. [DOI: 10.1101/753152] [Reference Citation Analysis]
524 da Silva CM, Caetano FH, Pereira FDC, Morales MAM, Sakane KK, Moraes KCM. Cellular and molecular effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts on retinoid metabolism in the human hepatic stellate cell LX-2. BMC Complement Altern Med 2019;19:222. [PMID: 31438947 DOI: 10.1186/s12906-019-2591-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
525 Mukherjee D, Ahmad R. COX-2/iNOS regulation during experimental hepatic injury and its mitigation by cloudy apple juice. Int J Biol Macromol 2019;140:1006-17. [PMID: 31445146 DOI: 10.1016/j.ijbiomac.2019.08.180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
526 Elias MB, Oliveira FL, Guma FCR, Martucci RB, Borojevic R, Teodoro AJ. Lycopene inhibits hepatic stellate cell activation and modulates cellular lipid storage and signaling. Food Funct 2019;10:1974-84. [PMID: 30889234 DOI: 10.1039/c8fo02369g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
527 Beck-Schimmer B, Roth Z'graggen B, Booy C, Köppel S, Spahn DR, Schläpfer M, Schadde E. Sevoflurane Protects Hepatocytes From Ischemic Injury by Reducing Reactive Oxygen Species Signaling of Hepatic Stellate Cells: Translational Findings Based on a Clinical Trial. Anesth Analg 2018;127:1058-65. [PMID: 30216289 DOI: 10.1213/ANE.0000000000003692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
528 Kaftanovskaya EM, Ng HH, Soula M, Rivas B, Myhr C, Ho BA, Cervantes BA, Shupe TD, Devarasetty M, Hu X, Xu X, Patnaik S, Wilson KJ, Barnaeva E, Ferrer M, Southall NT, Marugan JJ, Bishop CE, Agoulnik IU, Agoulnik AI. Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis. FASEB J 2019;33:12435-46. [PMID: 31419161 DOI: 10.1096/fj.201901046R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
529 Andrewartha N, Yeoh G. Human Amnion Epithelial Cell Therapy for Chronic Liver Disease. Stem Cells Int 2019;2019:8106482. [PMID: 31485235 DOI: 10.1155/2019/8106482] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
530 Kucherenko AM, Moroz LV, Bevz TI, Bulavenko VI, Antypkin YG, Berezenko VS, Dyba MB, Pampukha VM, Gorodna OV, Livshits LA. Investigation of rs11536889 + 3725G/C Polymorphism of the TLR4 Gene in Patients with Autoimmune and Chronic Viral Hepatitis C. Cytol Genet 2019;53:300-6. [DOI: 10.3103/s0095452719040078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
531 Kostallari E, Shah VH. Pericytes in the Liver. Adv Exp Med Biol 2019;1122:153-67. [PMID: 30937868 DOI: 10.1007/978-3-030-11093-2_9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
532 Aimaiti Y, Yusufukadier M, Li W, Tuerhongjiang T, Shadike A, Meiheriayi A, Gulisitan, Abudusalamu A, Wang H, Tuerganaili A, Shao Y, Wen H. TGF-β1 signaling activates hepatic stellate cells through Notch pathway. Cytotechnology 2019;71:881-91. [PMID: 31372876 DOI: 10.1007/s10616-019-00329-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
533 Wu Y, Li Z, Xiu AY, Meng DX, Wang SN, Zhang CQ. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice. Drug Des Devel Ther 2019;13:2667-76. [PMID: 31534314 DOI: 10.2147/DDDT.S210797] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
534 Liu N, Feng J, Lu X, Yao Z, Liu Q, Lv Y, Han Y, Deng J, Zhou Y. Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways. Mediators Inflamm 2019;2019:6175091. [PMID: 31467486 DOI: 10.1155/2019/6175091] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
535 Strowitzki MJ, Ritter AS, Kimmer G, Schneider M. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease? Pharmacol Res 2019;147:104364. [PMID: 31376431 DOI: 10.1016/j.phrs.2019.104364] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
536 Alukal JJ, Thuluvath PJ. Reversal of NASH fibrosis with pharmacotherapy. Hepatol Int 2019;13:534-45. [PMID: 31363910 DOI: 10.1007/s12072-019-09970-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
537 Hanson A, Piras IS, Wilhelmsen D, Still CD, Chu X, Petrick A, Gerhard GS, DiStefano JK. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p. Cytokine 2019;123:154789. [PMID: 31352173 DOI: 10.1016/j.cyto.2019.154789] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
538 Han W, Duan Z. Different drug metabolism behavior between species in drug-induced hepatotoxicity: limitations and novel resolutions. Toxin Reviews 2021;40:420-31. [DOI: 10.1080/15569543.2019.1639060] [Reference Citation Analysis]
539 Bruschi FV, Claudel T, Tardelli M, Starlinger P, Marra F, Trauner M. PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells. Hepatol Commun 2019;3:1191-204. [PMID: 31497741 DOI: 10.1002/hep4.1395] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
540 Lin HH, Peng YJ, Tsai MJ, Wu YY, Tsai TN, Huang HH, Shih YL, Chang WK, Hsieh TY. Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation. J Cell Physiol 2020;235:1689-99. [PMID: 31298420 DOI: 10.1002/jcp.29088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
541 Gao W, Sun J, Wang F, Lu Y, Wen C, Bian Q, Wu H. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway. Biochem Biophys Res Commun 2019;516:1222-8. [PMID: 31296386 DOI: 10.1016/j.bbrc.2019.07.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
542 Elzamly S, Agina HA, Elbalshy AE, Abuhashim M, Saad E, Abd Elmageed ZY. Integration of VEGF and α-SMA Expression Improves the Prediction Accuracy of Fibrosis in Chronic Hepatitis C Liver Biopsy. Appl Immunohistochem Mol Morphol 2017;25:261-70. [PMID: 26990742 DOI: 10.1097/PAI.0000000000000299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
543 Hu M, Wang Y, Xu L, An S, Tang Y, Zhou X, Li J, Liu R, Huang L. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nat Commun 2019;10:2993. [PMID: 31278269 DOI: 10.1038/s41467-019-10893-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 12.5] [Reference Citation Analysis]
544 Zhong L, Huang L, Xue Q, Liu C, Xu K, Shen W, Deng L. Cell-specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP-1 in high-fat diet-induced mice NAFLD. J Cell Biochem 2019;120:11761-74. [PMID: 30746746 DOI: 10.1002/jcb.28456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
545 Lin X, Li J, Xing Y. Geniposide, a sonic hedgehog signaling inhibitor, inhibits the activation of hepatic stellate cell. International Immunopharmacology 2019;72:330-8. [DOI: 10.1016/j.intimp.2019.04.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
546 Zmorzyński S, Styk W, Filip AA, Krasowska D. The Significance of NOTCH Pathway in the Development of Fibrosis in Systemic Sclerosis. Ann Dermatol 2019;31:365-71. [PMID: 33911613 DOI: 10.5021/ad.2019.31.4.365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
547 Robert S, Gicquel T, Bodin A, Fautrel A, Barreto E, Victoni T, Lagente V, Boichot E. Influence of inflammasome pathway activation in macrophages on the matrix metalloproteinase expression of human hepatic stellate cells. International Immunopharmacology 2019;72:12-20. [DOI: 10.1016/j.intimp.2019.03.060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
548 Susutlertpanya W, Wakuda H, Otani N, Kuramoto T, Li L, Kuranari M, Sekiguchi A, Kudo H, Uchida T, Imai H, Uemura N. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. Life Sciences 2019;228:251-7. [DOI: 10.1016/j.lfs.2019.05.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
549 Luo Y, Huo Y, Song P, Zhang X, Liao M. Validation and functional analysis of the critical proteins in combination with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats. Biomedicine & Pharmacotherapy 2019;115:108975. [DOI: 10.1016/j.biopha.2019.108975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
550 Ben-Moshe S, Itzkovitz S. Spatial heterogeneity in the mammalian liver. Nat Rev Gastroenterol Hepatol 2019;16:395-410. [PMID: 30936469 DOI: 10.1038/s41575-019-0134-x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 161] [Article Influence: 41.3] [Reference Citation Analysis]
551 Bae M, Lee Y, Park YK, Shin DG, Joshi P, Hong SH, Alder N, Koo SI, Lee JY. Astaxanthin attenuates the increase in mitochondrial respiration during the activation of hepatic stellate cells. J Nutr Biochem 2019;71:82-9. [PMID: 31302374 DOI: 10.1016/j.jnutbio.2019.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
552 Jain A, Barve A, Zhao Z, Fetse JP, Liu H, Li Y, Cheng K. Targeted Delivery of an siRNA/PNA Hybrid Nanocomplex Reverses Carbon Tetrachloride-Induced Liver Fibrosis. Adv Ther (Weinh) 2019;2:1900046. [PMID: 33072857 DOI: 10.1002/adtp.201900046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
553 Schulze RJ, Schott MB, Casey CA, Tuma PL, McNiven MA. The cell biology of the hepatocyte: A membrane trafficking machine. J Cell Biol 2019;218:2096-112. [PMID: 31201265 DOI: 10.1083/jcb.201903090] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 14.5] [Reference Citation Analysis]
554 Genz B, Coleman MA, Irvine KM, Kutasovic JR, Miranda M, Gratte FD, Tirnitz-Parker JEE, Olynyk JK, Calvopina DA, Weis A, Cloonan N, Robinson H, Hill MM, Al-Ejeh F, Ramm GA. Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells. Sci Rep 2019;9:8541. [PMID: 31189969 DOI: 10.1038/s41598-019-44865-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
555 Komolkriengkrai M, Nopparat J, Vongvatcharanon U, Anupunpisit V, Khimmaktong W. Effect of glabridin on collagen deposition in liver and amelioration of hepatocyte destruction in diabetes rats. Exp Ther Med 2019;18:1164-74. [PMID: 31316610 DOI: 10.3892/etm.2019.7664] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
556 Pham TX, Bae M, Kim MB, Lee Y, Hu S, Kang H, Park YK, Lee JY. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Biochim Biophys Acta Mol Basis Dis 2019;1865:2451-63. [PMID: 31195117 DOI: 10.1016/j.bbadis.2019.06.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
557 Kondo R, Akiba J, Ogasawara S, Nakashima O, Naito Y, Kusano H, Mihara Y, Tanigawa M, Yano H. Programmed death-ligand 1 expression is an unfavorable prognostic factor of hepatocellular carcinoma after archiving sustained virologic response for hepatitis C virus infection. Oncol Lett 2019;18:1458-66. [PMID: 31423211 DOI: 10.3892/ol.2019.10448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
558 Kompella P, Vasquez KM. Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability. Mol Carcinog 2019;58:1531-50. [PMID: 31168912 DOI: 10.1002/mc.23048] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
559 Choi W, Kim M, Jeong W. Functions of hepatic non-parenchymal cells in alcoholic liver disease. Liver Research 2019;3:80-7. [DOI: 10.1016/j.livres.2019.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
560 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
561 Chen L, Zhou Q, Liu E, Zhang J, Duan L, Zhu D, Chen J, Duan Y. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway. Parasit Vectors 2019;12:279. [PMID: 31151477 DOI: 10.1186/s13071-019-3539-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
562 Wang R, Song F, Li S, Wu B, Gu Y, Yuan Y. Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways. Drug Des Devel Ther 2019;13:1889-900. [PMID: 31213776 DOI: 10.2147/DDDT.S194787] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
563 Bae M, Kim MB, Kang H, Park YK, Lee JY. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells. Lipids 2019;54:401-10. [PMID: 31140624 DOI: 10.1002/lipd.12157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
564 Zhang K, Han Y, Hu Z, Zhang Z, Shao S, Yao Q, Zheng L, Wang J, Han X, Zhang Y, Chen T, Yao Z, Han T, Hong W. SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics 2019;9:3622-38. [PMID: 31281502 DOI: 10.7150/thno.32935] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
565 Carmona R, Barrena S, Muñoz-Chápuli R. Retinoids in Stellate Cells: Development, Repair, and Regeneration. J Dev Biol 2019;7:E10. [PMID: 31137700 DOI: 10.3390/jdb7020010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
566 Barcena-Varela M, Colyn L, Fernandez-Barrena MG. Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis. Int J Mol Sci 2019;20:E2507. [PMID: 31117267 DOI: 10.3390/ijms20102507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
567 Sanjeev S, Bidanchi RM, Murthy MK, Gurusubramanian G, Roy VK. Influence of ferulic acid consumption in ameliorating the cadmium-induced liver and renal oxidative damage in rats. Environ Sci Pollut Res Int 2019;26:20631-53. [PMID: 31104231 DOI: 10.1007/s11356-019-05420-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
568 Liu H, Zhang S, Xu S, Koroleva M, Small EM, Jin ZG. Myofibroblast-specific YY1 promotes liver fibrosis. Biochem Biophys Res Commun 2019;514:913-8. [PMID: 31084931 DOI: 10.1016/j.bbrc.2019.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
569 Gentilini A, Caligiuri A, Raggi C, Rombouts K, Pinzani M, Lori G, Correnti M, Invernizzi P, Rovida E, Navari N, Di Matteo S, Alvaro D, Banales JM, Rodrigues P, Raschioni C, Donadon M, Di Tommaso L, Marra F. CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2246-2256. [PMID: 31059778 DOI: 10.1016/j.bbadis.2019.04.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
570 Fais P, Leopizzi M, Di Maio V, Longo L, Della Rocca C, Tagliaro F, Bortolotti F, Lo Vasco VR. Phosphoinositide-specific phospholipase C in normal human liver and in alcohol abuse. J Cell Biochem 2019;120:7907-17. [PMID: 30426534 DOI: 10.1002/jcb.28067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
571 Li X, Liu Y, Yue W, Tan Y, Wang H, Zhang L, Chen J. A Compound of Chinese Herbs Protects against Alcoholic Liver Fibrosis in Rats via the TGF-β1/Smad Signaling Pathway. Evid Based Complement Alternat Med 2019;2019:9121347. [PMID: 31118972 DOI: 10.1155/2019/9121347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
572 Yeh YH, Liang CY, Chen ML, Tsai FM, Lin YY, Lee MC, Wu JS, Kuo CY. Apoptotic effects of hsian-tsao (Mesona procumbens Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase-3 pathways. Food Sci Nutr 2019;7:1891-8. [PMID: 31139404 DOI: 10.1002/fsn3.1046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
573 Elzeftawy A, Mansour L, Kobtan A, Mourad H, El-Kalla F. Evaluation of the blood ammonia level as a non-invasive predictor for the presence of esophageal varices and the risk of bleeding. Turk J Gastroenterol 2019;30:59-65. [PMID: 30465524 DOI: 10.5152/tjg.2018.17894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
574 Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
575 Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in Crossref: 102] [Cited by in F6Publishing: 115] [Article Influence: 25.5] [Reference Citation Analysis]
576 Ju B, Nie Y, Yang X, Wang X, Li F, Wang M, Wang C, Zhang H. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells. J Cell Mol Med. 2019;23:3824-3832. [PMID: 30945448 DOI: 10.1111/jcmm.14210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
577 Bang BR, Li M, Tsai KN, Aoyagi H, Lee SA, Machida K, Aizaki H, Jung JU, Ou JJ, Saito T. Regulation of Hepatitis C Virus Infection by Cellular Retinoic Acid Binding Proteins through the Modulation of Lipid Droplet Abundance. J Virol 2019;93:e02302-18. [PMID: 30728260 DOI: 10.1128/JVI.02302-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
578 Pingitore P, Sasidharan K, Ekstrand M, Prill S, Lindén D, Romeo S. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis. Int J Mol Sci 2019;20:E1629. [PMID: 30986904 DOI: 10.3390/ijms20071629] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
579 Anfuso B, Giraudi PJ, Tiribelli C, Rosso N. Silybin Modulates Collagen Turnover in an In Vitro Model of NASH. Molecules 2019;24:E1280. [PMID: 30986937 DOI: 10.3390/molecules24071280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
580 Shi M, Dong B, Yang W, Su S, Zhang H. Preventive and therapeutic role of Tanshinone ⅡA in hepatology. Biomedicine & Pharmacotherapy 2019;112:108676. [DOI: 10.1016/j.biopha.2019.108676] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
581 Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int 2019;39:598-609. [PMID: 30312513 DOI: 10.1111/liv.13986] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
582 Traustadóttir GÁ, Lagoni LV, Ankerstjerne LBS, Bisgaard HC, Jensen CH, Andersen DC. The imprinted gene Delta like non-canonical Notch ligand 1 (Dlk1) is conserved in mammals, and serves a growth modulatory role during tissue development and regeneration through Notch dependent and independent mechanisms. Cytokine & Growth Factor Reviews 2019;46:17-27. [DOI: 10.1016/j.cytogfr.2019.03.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
583 Ganey PE, Misek SA. Signal Transduction in Disease. Cellular Signal Transduction in Toxicology and Pharmacology 2019. [DOI: 10.1002/9781119060208.ch4] [Reference Citation Analysis]
584 Wang K, Fang S, Liu Q, Gao J, Wang X, Zhu H, Zhu Z, Ji F, Wu J, Ma Y, Hu L, Shen X, Gao D, Zhu J, Liu P, Zhou H. TGF-β1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAM. EBioMedicine 2019;42:458-69. [PMID: 30926424 DOI: 10.1016/j.ebiom.2019.03.058] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
585 Davidson MD, Song KH, Lee MH, Llewellyn J, Du Y, Baker BM, Wells RG, Burdick JA. Engineered Fibrous Networks To Investigate the Influence of Fiber Mechanics on Myofibroblast Differentiation. ACS Biomater Sci Eng 2019;5:3899-908. [PMID: 33438429 DOI: 10.1021/acsbiomaterials.8b01276] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
586 Scheiner B, Ulbrich G, Mandorfer M, Reiberger T, Müller C, Waneck F, Trauner M, Kölblinger C, Ferlitsch A, Sieghart W, Peck-Radosavljevic M, Pinter M. Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. United European Gastroenterol J 2019;7:850-8. [PMID: 31316789 DOI: 10.1177/2050640619840199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
587 Sulaiman SA, Muhsin NIA, Jamal R. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease. Front Physiol 2019;10:279. [PMID: 30941061 DOI: 10.3389/fphys.2019.00279] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
588 Yokomori H, Ando W, Oda M. Cavin-1 is linked to lipid droplet formation in human hepatic stellate cells. Med Mol Morphol 2020;53:56-9. [PMID: 30877476 DOI: 10.1007/s00795-019-00219-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
589 Zhong L, Huang S, Du X, Cai C, Zhou Y, Shen W, Deng L, Ning B. Liver X Receptor β Controls Hepatic Stellate Cell Activation via Hedgehog Signaling.. [DOI: 10.1101/577833] [Reference Citation Analysis]
590 Meier RPH, Meyer J, Montanari E, Lacotte S, Balaphas A, Muller YD, Clément S, Negro F, Toso C, Morel P, Buhler LH. Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner. Int J Mol Sci 2019;20:E1295. [PMID: 30875826 DOI: 10.3390/ijms20061295] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
591 Blau BJ, Miki T. The role of cellular interactions in the induction of hepatocyte polarity and functional maturation in stem cell-derived hepatic cells. Differentiation. 2019;106:42-48. [PMID: 30878880 DOI: 10.1016/j.diff.2019.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
592 Perugorria MJ, Esparza-Baquer A, Oakley F, Labiano I, Korosec A, Jais A, Mann J, Tiniakos D, Santos-Laso A, Arbelaiz A, Gawish R, Sampedro A, Fontanellas A, Hijona E, Jimenez-Agüero R, Esterbauer H, Stoiber D, Bujanda L, Banales JM, Knapp S, Sharif O, Mann DA. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage. Gut 2019;68:533-46. [PMID: 29374630 DOI: 10.1136/gutjnl-2017-314107] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 15.0] [Reference Citation Analysis]
593 Saravanakumar A, Periyasamy P, Jang HT. In vitro assessment of three different artemisia species for their antioxidant and anti-fibrotic activity. Biocatalysis and Agricultural Biotechnology 2019;18:101040. [DOI: 10.1016/j.bcab.2019.101040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Imai Y, Yoshida O, Watanabe T, Yukimoto A, Koizumi Y, Ikeda Y, Tokumoto Y, Hirooka M, Abe M, Hiasa Y. Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation. PLoS One 2019;14:e0212589. [PMID: 30794626 DOI: 10.1371/journal.pone.0212589] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
595 Marcher AB, Bendixen SM, Terkelsen MK, Hohmann SS, Hansen MH, Larsen BD, Mandrup S, Dimke H, Detlefsen S, Ravnskjaer K. Transcriptional regulation of Hepatic Stellate Cell activation in NASH. Sci Rep 2019;9:2324. [PMID: 30787418 DOI: 10.1038/s41598-019-39112-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
596 Guidolin D, Marcoli M, Tortorella C, Maura G, Agnati LF. Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development? Front Endocrinol (Lausanne) 2019;10:53. [PMID: 30833931 DOI: 10.3389/fendo.2019.00053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
597 Miyoshi M, Kakinuma S, Kamiya A, Tsunoda T, Tsuchiya J, Sato A, Kaneko S, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Nakauchi H, Asahina Y, Watanabe M. LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Sci Rep 2019;9:2072. [PMID: 30765795 DOI: 10.1038/s41598-018-37430-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
598 El-Naggar ME, Al-Joufi F, Anwar M, Attia MF, El-Bana MA. Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats. Colloids Surf B Biointerfaces 2019;177:389-98. [PMID: 30785036 DOI: 10.1016/j.colsurfb.2019.02.024] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 15.3] [Reference Citation Analysis]
599 Jing F, Geng Y, Xu XY, Xu HY, Shi JS, Xu ZH. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1. Int J Mol Sci 2019;20:E796. [PMID: 30781750 DOI: 10.3390/ijms20040796] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
600 Yang HY, Kim KS, Lee YH, Park JH, Kim JH, Lee SY, Kim YM, Kim IS, Kacew S, Lee BM, Kwak JH, Yoon K, Kim HS. Dendropanax morbifera Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways. Int J Biol Sci 2019;15:800-11. [PMID: 30906211 DOI: 10.7150/ijbs.30356] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
601 Wang F, Jia Y, Li M, Wang L, Shao J, Guo Q, Tan S, Ding H, Chen A, Zhang F, Zheng S. Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells. Cell Commun Signal 2019;17:11. [PMID: 30744642 DOI: 10.1186/s12964-019-0324-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
602 Jiang B, Huang J, Yu Z, Wu M, Liu M, Yao J, Zhao H, Yan G, Ying W, Cao W, Yang P. A multi-parallel N-glycopeptide enrichment strategy for high-throughput and in-depth mapping of the N-glycoproteome in metastatic human hepatocellular carcinoma cell lines. Talanta 2019;199:254-61. [PMID: 30952254 DOI: 10.1016/j.talanta.2019.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
603 Shmarakov IO, Jiang H, Liu J, Fernandez EJ, Blaner WS. Hepatic stellate cell activation: A source for bioactive lipids. Biochim Biophys Acta Mol Cell Biol Lipids 2019;1864:629-42. [PMID: 30735856 DOI: 10.1016/j.bbalip.2019.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
604 Mannaerts I, Thoen LFR, Eysackers N, Cubero FJ, Batista Leite S, Coldham I, Colle I, Trautwein C, van Grunsven LA. Unfolded protein response is an early, non-critical event during hepatic stellate cell activation. Cell Death Dis 2019;10:98. [PMID: 30718473 DOI: 10.1038/s41419-019-1327-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
605 Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L, Banales JM. Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol 2019;16:121-36. [PMID: 30451972 DOI: 10.1038/s41575-018-0075-9] [Cited by in Crossref: 199] [Cited by in F6Publishing: 201] [Article Influence: 49.8] [Reference Citation Analysis]
606 Yokomori H, Ando W, Oda M. Caveolin-1 is related to lipid droplet formation in hepatic stellate cells in human liver. Acta Histochem 2019;121:113-8. [PMID: 30446170 DOI: 10.1016/j.acthis.2018.10.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
607 Kato H, Duarte S, Miller MG, Busuttil RW, Coito AJ. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. Liver Transpl 2019;25:288-301. [PMID: 30358115 DOI: 10.1002/lt.25365] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
608 Zhang R, Lin X, Liu H, Ma M, Chen J, Chen J, Gao D, Cui J, Chen R. Activated hepatic stellate cells promote progression of post-heat residual hepatocellular carcinoma from autophagic survival to proliferation. International Journal of Hyperthermia 2019;36:252-62. [DOI: 10.1080/02656736.2018.1558459] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
609 Ghafoory S, Varshney R, Robison T, Kouzbari K, Woolington S, Murphy B, Xia L, Ahamed J. Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury. Blood Adv 2018;2:470-80. [PMID: 29490978 DOI: 10.1182/bloodadvances.2017010868] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
610 Blaner WS. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacol Ther. 2019;197:153-178. [PMID: 30703416 DOI: 10.1016/j.pharmthera.2019.01.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 125] [Article Influence: 29.5] [Reference Citation Analysis]
611 Kerola A, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Divergent expression of liver transforming growth factor superfamily cytokines after successful portoenterostomy in biliary atresia. Surgery 2019;165:905-11. [PMID: 30686515 DOI: 10.1016/j.surg.2018.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
612 Gjorgjieva M, Mithieux G, Rajas F. Hepatic stress associated with pathologies characterized by disturbed glucose production. Cell Stress 2019;3:86-99. [PMID: 31225503 DOI: 10.15698/cst2019.03.179] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
613 Akil A, Endsley M, Shanmugam S, Saldarriaga O, Somasunderam A, Spratt H, Stevenson HL, Utay NS, Ferguson M, Yi M. Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System. Sci Rep 2019;9:568. [PMID: 30679661 DOI: 10.1038/s41598-018-37071-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
614 Melis M, Tang XH, Trasino SE, Patel VM, Stummer DJ, Jessurun J, Gudas LJ. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLoS One. 2019;14:e0211071. [PMID: 30677086 DOI: 10.1371/journal.pone.0211071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
615 Gonçalves LR, de Oliveira da Silva B, Scarinci LD, Ramos LF, Moraes KC. MicroRNA-1254 contributes to the controlling of pro-fibrogenic environment in LX-2 cells by modulating SMAD3 and wound repair: new insights in hepatic fibrosis: MicroRNA-1254 contributes to the controlling of pro-fibrogenic environment. Cell Biol Int 2019;43:333-43. [DOI: 10.1002/cbin.11075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
616 Verma A, Bennett J, Örme AM, Polycarpou E, Rooney B. Cocaine addicted to cytoskeletal change and a fibrosis high. Cytoskeleton (Hoboken) 2019;76:177-85. [PMID: 30623590 DOI: 10.1002/cm.21510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
617 Wang Z, Tao Y, Qiu T, Yao X, Jiang L, Wang N, Wei S, Jia X, Pei P, Yang G, Liu X, Liu S, Sun X. Taurine protected As2O3-induced the activation of hepatic stellate cells through inhibiting PPARα-autophagy pathway. Chem Biol Interact 2019;300:123-30. [PMID: 30677399 DOI: 10.1016/j.cbi.2019.01.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
618 Kim JH, Lee CH, Lee SW. Exosomal Transmission of MicroRNA from HCV Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells. Mol Ther Nucleic Acids. 2019;14:483-497. [PMID: 30753992 DOI: 10.1016/j.omtn.2019.01.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
619 Navarro-Corcuera A, López-Zabalza MJ, Martínez-Irujo JJ, Álvarez-Sola G, Ávila MA, Iraburu MJ, Ansorena E, Montiel-Duarte C. Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells. Biochim Biophys Acta Mol Cell Res 2019;1866:673-85. [PMID: 30660615 DOI: 10.1016/j.bbamcr.2019.01.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
620 Shao S, Duan W, Xu Q, Li X, Han L, Li W, Zhang D, Wang Z, Lei J. Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF. Oxid Med Cell Longev 2019;2019:8148510. [PMID: 30800209 DOI: 10.1155/2019/8148510] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
621 Wang P, Lei S, Wang X, Xu W, Hu P, Chen F, Zhang X, Yin C, Xie W. MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1. Biochem Cell Biol 2019;97:505-12. [PMID: 30645141 DOI: 10.1139/bcb-2018-0211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
622 Varabei AV, Shuleika AC, Vladimirskay TE, Shved IA, Vizhinis YI, Makki MY. Hypoxia of pancreas in pathogenesis of fibrosis in chronic pancreatitis. Vescì Nac akad navuk Belarusì, Ser med navuk 2019;15:391-404. [DOI: 10.29235/1814-6023-2018-15-4-391-404] [Reference Citation Analysis]
623 Luo XY, Meng XJ, Cao DC, Wang W, Zhou K, Li L, Guo M, Wang P. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes. Stem Cell Res Ther. 2019;10:16. [PMID: 30635047 DOI: 10.1186/s13287-018-1122-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
624 Tao J, Li S, Gan RY, Zhao CN, Meng X, Li HB. Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action. Crit Rev Food Sci Nutr 2020;60:1025-37. [PMID: 30632784 DOI: 10.1080/10408398.2018.1555789] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
625 Gnecchi M, Ciuffreda MC, Mura M. Mesenchymal Stromal Cell Secretome for Tissue Repair. Cell Engineering and Regeneration 2019. [DOI: 10.1007/978-3-319-37076-7_43-1] [Reference Citation Analysis]
626 Lebedeva EI, Vitebsk State Order of Peoples' Friendship Medical University, Myadelets OD, Vitebsk State Order of Peoples' Friendship Medical University. CELLULAR AND MOLECULAR MECHANISMS OF LIVER FIBROGENESIS. Hepatol Gastroenterol 2019;3:119-126. [DOI: 10.25298/2616-5546-2019-3-2-119-126] [Reference Citation Analysis]
627 Chen Y, Sun W, Kang L, Wang Y, Zhang M, Zhang H, Hu P. Microfluidic co-culture of liver tumor spheroids with stellate cells for the investigation of drug resistance and intercellular interactions. Analyst 2019;144:4233-40. [DOI: 10.1039/c9an00612e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
628 Vivero-escoto JL, Vadarevu H, Juneja R, Schrum LW, Benbow JH. Nanoparticle mediated silencing of tenascin C in hepatic stellate cells: effect on inflammatory gene expression and cell migration. J Mater Chem B 2019;7:7396-405. [DOI: 10.1039/c9tb01845j] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
629 Jonscher KR, Rucker RB. Pyrroloquinoline Quinone. Dietary Interventions in Liver Disease 2019. [DOI: 10.1016/b978-0-12-814466-4.00013-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
630 Zhang Y, Miao H, Guan H, Wang C, Wang Z, Ji L. Long-term diosbulbin B treatment induced liver fibrosis in mice. Chemico-Biological Interactions 2019;298:15-23. [DOI: 10.1016/j.cbi.2018.10.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
631 Hoare M. Mechanisms of Disease: The Damaged Genome in HCC. Liver Cancers 2019. [DOI: 10.1007/978-3-319-92216-4_4] [Reference Citation Analysis]
632 Guido M, Sarcognato S, Sacchi D, Ludwig K. The Anatomy and Histology of the Liver and Biliary Tract. Pediatric Hepatology and Liver Transplantation 2019. [DOI: 10.1007/978-3-319-96400-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
633 Chen JY, Thakar D, Chang TT. Liver Fibrosis: Current Approaches and Future Directions for Diagnosis and Treatment. Molecular and Translational Medicine 2019. [DOI: 10.1007/978-3-319-98143-7_15] [Reference Citation Analysis]
634 Ulmasov B, Noritake H, Carmichael P, Oshima K, Griggs DW, Neuschwander-Tetri BA. An Inhibitor of Arginine-Glycine-Aspartate-Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis. Hepatol Commun 2019;3:246-61. [PMID: 30766962 DOI: 10.1002/hep4.1298] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
635 Costain AH, MacDonald AS, Smits HH. Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses. Front Immunol 2018;9:3042. [PMID: 30619372 DOI: 10.3389/fimmu.2018.03042] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 15.4] [Reference Citation Analysis]
636 Vickers AEM, Ulyanov AV, Fisher RL. Progression of Repair and Injury in Human Liver Slices. Int J Mol Sci 2018;19:E4130. [PMID: 30572671 DOI: 10.3390/ijms19124130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
637 Ilangumaran S, Moriggl R, Kalvakolanu DV. Editorial: Cytokines in liver diseases. Cytokine 2019;124:154608. [PMID: 30563739 DOI: 10.1016/j.cyto.2018.12.001] [Reference Citation Analysis]
638 Xiong X, Wang Q, Wang S, Zhang J, Liu T, Guo L, Yu Y, Lin JD. Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. Mol Metab 2019;20:128-37. [PMID: 30595550 DOI: 10.1016/j.molmet.2018.12.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 10.8] [Reference Citation Analysis]
639 Thi Thanh Hai N, Thuy LTT, Shiota A, Kadono C, Daikoku A, Hoang DV, Dat NQ, Sato-Matsubara M, Yoshizato K, Kawada N. Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice. Sci Rep 2018;8:17860. [PMID: 30552362 DOI: 10.1038/s41598-018-36215-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
640 Shmagel K, Saidakova E. Immune Disorders in HIV-Infected Patients Coinfected with Hepatitis C Virus. Advances in HIV and AIDS Control 2018. [DOI: 10.5772/intechopen.76810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
641 Ding HR, Wang JL, Ren HZ, Shi XL. Lipometabolism and Glycometabolism in Liver Diseases. Biomed Res Int 2018;2018:1287127. [PMID: 31205932 DOI: 10.1155/2018/1287127] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
642 Yuan B, Chen Y, Wu Z, Zhang L, Zhuang Y, Zhao X, Niu H, Cheng JC, Zeng Z. Proteomic Profiling of Human Hepatic Stellate Cell Line LX2 Responses to Irradiation and TGF-β1. J Proteome Res 2019;18:508-21. [PMID: 30489086 DOI: 10.1021/acs.jproteome.8b00814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
643 Zheng H, You Y, Hua M, Wu P, Liu Y, Chen Z, Zhang L, Wei H, Li Y, Luo M, Zeng Y, Liu Y, Luo DX, Zhang J, Feng M, Hu R, Pandol SJ, Han YP. Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice. Front Physiol 2018;9:1671. [PMID: 30564133 DOI: 10.3389/fphys.2018.01671] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
644 Cannito S, Milani C, Cappon A, Parola M, Strazzabosco M, Cadamuro M. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies. Int J Mol Sci. 2018;19. [PMID: 30518128 DOI: 10.3390/ijms19123875] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
645 Loeuillard E, El Mourabit H, Lei L, Lemoinne S, Housset C, Cadoret A. Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:3688-96. [DOI: 10.1016/j.bbadis.2018.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
646 Maeso-Díaz R, Ortega-Ribera M, Fernández-Iglesias A, Hide D, Muñoz L, Hessheimer AJ, Vila S, Francés R, Fondevila C, Albillos A, Peralta C, Bosch J, Tacke F, Cogger VC, Gracia-Sancho J. Effects of aging on liver microcirculatory function and sinusoidal phenotype. Aging Cell 2018;17:e12829. [PMID: 30260562 DOI: 10.1111/acel.12829] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 12.0] [Reference Citation Analysis]
647 Orbach SM, Ford AJ, Saverot SE, Rajagopalan P. Multi-cellular transitional organotypic models to investigate liver fibrosis. Acta Biomater 2018;82:79-92. [PMID: 30316024 DOI: 10.1016/j.actbio.2018.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
648 Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomedicine & Pharmacotherapy 2018;108:1617-27. [DOI: 10.1016/j.biopha.2018.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
649 Chong YC, Lim TE, Fu Y, Shin EM, Tergaonkar V, Han W. Indian Hedgehog links obesity to development of hepatocellular carcinoma. Oncogene 2019;38:2206-22. [PMID: 30470823 DOI: 10.1038/s41388-018-0585-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
650 Zhu C, Kim K, Wang X, Bartolome A, Salomao M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, Schwabe RF, Tabas I, Valenti L, Lavine JE, Pajvani UB. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med 2018;10. [PMID: 30463916 DOI: 10.1126/scitranslmed.aat0344] [Cited by in Crossref: 96] [Cited by in F6Publishing: 98] [Article Influence: 19.2] [Reference Citation Analysis]
651 Puchalska P, Martin SE, Huang X, Lengfeld JE, Daniel B, Graham MJ, Han X, Nagy L, Patti GJ, Crawford PA. Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis. Cell Metab 2019;29:383-398.e7. [PMID: 30449686 DOI: 10.1016/j.cmet.2018.10.015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
652 Widjaja AA, Singh BK, Adami E, Viswanathan S, D’agostino GA, Dong J, Ng B, Tan J, Paleja BS, Tripathi M, Lim SY, Chothani SP, Lim WW, Rabes A, Sombetzki M, Bruinstroop E, Sinha RA, Albani S, Yen PM, Schafer S, Cook SA. IL-11 neutralising therapies target hepatic stellate cell-induced liver inflammation and fibrosis in NASH.. [DOI: 10.1101/470062] [Reference Citation Analysis]
653 Schyman P, Printz RL, Estes SK, Boyd KL, Shiota M, Wallqvist A. Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney. Front Pharmacol 2018;9:1272. [PMID: 30459623 DOI: 10.3389/fphar.2018.01272] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
654 Chen Z, Guo P, Xie X, Yu H, Wang Y, Chen G. The role of tumour microenvironment: a new vision for cholangiocarcinoma. J Cell Mol Med. 2019;23:59-69. [PMID: 30394682 DOI: 10.1111/jcmm.13953] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
655 Jophlin LL, Koutalos Y, Chen C, Shah V, Rockey DC. Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2018;315:G713-21. [PMID: 30024770 DOI: 10.1152/ajpgi.00251.2017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
656 Ai W, Dong L, Wang J, Li Z, Wang X, Gao J, Wu Y, An W. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:3780-91. [DOI: 10.1016/j.bbadis.2018.09.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
657 Bessone F, Dirchwolf M, Rodil MA, Razori MV, Roma MG. Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. Aliment Pharmacol Ther 2018;48:892-913. [PMID: 30194708 DOI: 10.1111/apt.14952] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 9.8] [Reference Citation Analysis]
658 Lung T, Risch L, Risch M, Sakem B, Würzner R, Nydegger U. The utility of complement assays in clinical immunology: A comprehensive review. J Autoimmun 2018;95:191-200. [PMID: 30391025 DOI: 10.1016/j.jaut.2018.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
659 Ji F, Wang K, Zhang Y, Mao XL, Huang Q, Wang J, Ye L, Li Y. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7. J Cell Biochem 2019;120:4573-81. [PMID: 30368874 DOI: 10.1002/jcb.27746] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
660 Zhu J, Luo Z, Pan Y, Zheng W, Li W, Zhang Z, Xiong P, Xu D, Du M, Wang B, Yu J, Zhang J, Liu J. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes. J Cell Physiol 2019;234:9698-710. [PMID: 30362572 DOI: 10.1002/jcp.27656] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
661 Qinna NA, Ghanim BY. Chemical induction of hepatic apoptosis in rodents. J Appl Toxicol 2019;39:178-90. [PMID: 30350376 DOI: 10.1002/jat.3740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
662 Jiang ZJ, Shen QH, Chen HY, Yang Z, Shuai MQ, Zheng SS. Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis. Int J Mol Med 2019;43:103-16. [PMID: 30365068 DOI: 10.3892/ijmm.2018.3950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
663 Cui G, Chen J, Wu Z, Huang H, Wang L, Liang Y, Zeng P, Yang J, Uede T, Diao H. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis. J Cell Physiol. 2019;234:8988-8997. [PMID: 30350863 DOI: 10.1002/jcp.27571] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
664 Kim DK, Cho YE, Komarow HD, Bandara G, Song BJ, Olivera A, Metcalfe DD. Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation. Proc Natl Acad Sci U S A 2018;115:E10692-701. [PMID: 30352845 DOI: 10.1073/pnas.1809938115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
665 Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76:99-128. [PMID: 30343320 DOI: 10.1007/s00018-018-2947-0] [Cited by in Crossref: 202] [Cited by in F6Publishing: 185] [Article Influence: 40.4] [Reference Citation Analysis]
666 Cai FF, Wu R, Song YN, Xiong AZ, Chen XL, Yang MD, Yang L, Hu Y, Sun MY, Su SB. Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway. Sci Rep 2018;8:15367. [PMID: 30337590 DOI: 10.1038/s41598-018-33669-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
667 Stradiot L, Mannaerts I, van Grunsven LA. P311, Friend, or Foe of Tissue Fibrosis? Front Pharmacol 2018;9:1151. [PMID: 30369881 DOI: 10.3389/fphar.2018.01151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
668 Huang Q, Wei J, Wei L, Zhang X, Bai F, Wen S, Wei Y, Tan S, Lu Z, Lin X. Retracted : Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis. J Cell Biochem 2019;120:6168-77. [DOI: 10.1002/jcb.27904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
669 Luo X, Zhang D, Xie J, Su Q, He X, Bai R, Gao G, Pan W. MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7. Mol Ther Methods Clin Dev 2018;11:73-82. [PMID: 30406154 DOI: 10.1016/j.omtm.2018.10.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
670 Wang C, Wang B, Xue L, Kang Z, Hou S, Du J, Zhang C. Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton. J Med Chem 2018;61:10573-87. [DOI: 10.1021/acs.jmedchem.8b01165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
671 Bansal MB, Chamroonkul N. Antifibrotics in liver disease: are we getting closer to clinical use? Hepatol Int. 2019;13:25-39. [PMID: 30302735 DOI: 10.1007/s12072-018-9897-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
672 Fu Q, Ohnishi S, Sakamoto N. Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells. Stem Cells Int 2018;2018:4898152. [PMID: 30402110 DOI: 10.1155/2018/4898152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
673 Cook D, Achanta S, Hoek JB, Ogunnaike BA, Vadigepalli R. Cellular network modeling and single cell gene expression analysis reveals novel hepatic stellate cell phenotypes controlling liver regeneration dynamics. BMC Syst Biol 2018;12:86. [PMID: 30285726 DOI: 10.1186/s12918-018-0605-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
674 Goodus MT, Sauerbeck AD, Popovich PG, Bruno RS, McTigue DM. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but Does Not Improve Chronic Hepatic and Spinal Cord Pathology in Rats. J Neurotrauma 2018;35:2872-82. [PMID: 30084733 DOI: 10.1089/neu.2018.5771] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
675 Strowitzki MJ, Kirchberg J, Tuffs C, Schiedeck M, Ritter AS, Biller M, Harnoss JM, Lasitschka F, Schmidt T, Radhakrishnan P, Ulrich A, Schneider M. Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells. Am J Pathol 2018;188:2826-38. [PMID: 30248340 DOI: 10.1016/j.ajpath.2018.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
676 Gentilini A, Pastore M, Marra F, Raggi C. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. Int J Mol Sci. 2018;19. [PMID: 30249019 DOI: 10.3390/ijms19102885] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
677 Zhang R, Kikuchi AT, Nakao T, Russell JO, Preziosi ME, Poddar M, Singh S, Bell AW, England SG, Monga SP. Elimination of Wnt Secretion From Stellate Cells Is Dispensable for Zonation and Development of Liver Fibrosis Following Hepatobiliary Injury. Gene Expr 2019;19:121-36. [PMID: 30236172 DOI: 10.3727/105221618X15373858350141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
678 Gupta G, Khadem F, Uzonna JE. Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity. Cytokine 2019;124:154542. [PMID: 30241896 DOI: 10.1016/j.cyto.2018.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
679 Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G, Mathurin P, Urrutia R, Huebert RC, Shah VH. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis. Cell Mol Gastroenterol Hepatol 2019;7:197-209. [PMID: 30539787 DOI: 10.1016/j.jcmgh.2018.09.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
680 Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37-55. [PMID: 30213667 DOI: 10.1016/j.mam.2018.09.002] [Cited by in Crossref: 286] [Cited by in F6Publishing: 314] [Article Influence: 57.2] [Reference Citation Analysis]
681 Yang L, Li LC, Lamaoqiezhong, Wang X, Wang WH, Wang YC, Xu CR. The contributions of mesoderm-derived cells in liver development. Semin Cell Dev Biol 2019;92:63-76. [PMID: 30193996 DOI: 10.1016/j.semcdb.2018.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
682 Jia Y, Wang F, Guo Q, Li M, Wang L, Zhang Z, Jiang S, Jin H, Chen A, Tan S, Zhang F, Shao J, Zheng S. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells. Redox Biol 2018;19:375-87. [PMID: 30237126 DOI: 10.1016/j.redox.2018.09.007] [Cited by in Crossref: 77] [Cited by in F6Publishing: 83] [Article Influence: 15.4] [Reference Citation Analysis]
683 Dattaroy D, Seth RK, Sarkar S, Kimono D, Albadrani M, Chandrashekaran V, Hasson FA, Singh UP, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM, Chatterjee S. Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent. Eur J Pharmacol 2018;841:33-48. [PMID: 30194936 DOI: 10.1016/j.ejphar.2018.08.040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
684 Xiang DM, Sun W, Ning BF, Zhou TF, Li XF, Zhong W, Cheng Z, Xia MY, Wang X, Deng X, Wang W, Li HY, Cui XL, Li SC, Wu B, Xie WF, Wang HY, Ding J. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut 2018;67:1704-15. [PMID: 28754776 DOI: 10.1136/gutjnl-2016-313392] [Cited by in Crossref: 93] [Cited by in F6Publishing: 103] [Article Influence: 18.6] [Reference Citation Analysis]
685 Qu C, Zheng D, Li S, Liu Y, Lidofsky A, Holmes JA, Chen J, He L, Wei L, Liao Y, Yuan H, Jin Q, Lin Z, Hu Q, Jiang Y, Tu M, Chen X, Li W, Lin W, Fuchs BC, Chung RT, Hong J. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology 2018;68:1125-39. [PMID: 29537660 DOI: 10.1002/hep.29881] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 10.6] [Reference Citation Analysis]
686 Le Guilcher C, Garcin I, Dellis O, Cauchois F, Tebbi A, Doignon I, Guettier C, Julien B, Tordjmann T. The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis. J Hepatol 2018;69:644-53. [PMID: 29802948 DOI: 10.1016/j.jhep.2018.05.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
687 Vickers AE, Fisher RL. Human Liver Slices to Investigate Injury and Repair. Applied In Vitro Toxicology 2018;4:280-7. [DOI: 10.1089/aivt.2018.0017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
688 Hatton G, Alterio T, Nobili V, Mann JP. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future? Expert Review of Gastroenterology & Hepatology 2018;12:961-7. [DOI: 10.1080/17474124.2018.1512853] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
689 Hanson A, Wilhelmsen D, DiStefano JK. The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD). Noncoding RNA 2018;4:E18. [PMID: 30134610 DOI: 10.3390/ncrna4030018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
690 Bale SS, Borenstein JT. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions. Drug Metab Dispos 2018;46:1638-46. [DOI: 10.1124/dmd.118.083055] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
691 Feili X, Wu S, Ye W, Tu J, Lou L. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells. Cell Biol Int 2018;42:1370-6. [PMID: 29957876 DOI: 10.1002/cbin.11022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
692 Grouix B, Sarra-Bournet F, Leduc M, Simard JC, Hince K, Geerts L, Blais A, Gervais L, Laverdure A, Felton A, Richard J, Ouboudinar J, Gagnon W, Leblond FA, Laurin P, Gagnon L. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway. J Pharmacol Exp Ther 2018;367:71-81. [PMID: 30093459 DOI: 10.1124/jpet.118.250068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
693 Marchyshak T, Yakovenko T, Shmarakov I, Tkachuk Z. The Potential Protective Effect of Oligoribonucleotides-d-Mannitol Complexes against Thioacetamide-Induced Hepatotoxicity in Mice. Pharmaceuticals (Basel) 2018;11:E77. [PMID: 30082619 DOI: 10.3390/ph11030077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
694 Papadopoulos N, Lennartsson J. The PDGF/PDGFR pathway as a drug target. Molecular Aspects of Medicine 2018;62:75-88. [DOI: 10.1016/j.mam.2017.11.007] [Cited by in Crossref: 122] [Cited by in F6Publishing: 100] [Article Influence: 24.4] [Reference Citation Analysis]
695 Ogawa Y, Imajo K, Honda Y, Kessoku T, Tomeno W, Kato S, Fujita K, Yoneda M, Saito S, Saigusa Y, Hyogo H, Sumida Y, Itoh Y, Eguchi K, Yamanaka T, Wada K, Nakajima A. Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. Sci Rep 2018;8:11365. [PMID: 30054551 DOI: 10.1038/s41598-018-29735-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
696 Marchyshak T, Institute of Molecular Biology and Genetics of the NAS of Ukraine, Kyiv, Yakovenko T, Tkachuk Z, Institute of Molecular Biology and Genetics of the NAS of Ukraine, Kyiv, Institute of Molecular Biology and Genetics of the NAS of Ukraine, Kyiv. Influence of oligoribonucleotides-D-mannitol complexes on the expression of genes under acute thioacetamide-induced hepatotoxicity. Dopov Nac akad nauk Ukr 2018. [DOI: 10.15407/dopovidi2018.07.096] [Reference Citation Analysis]
697 Al-Humadi H, Alhumadi A, Al-Saigh R, Strilakou A, Lazaris AC, Gazouli M, Liapi C. "Extracellular matrix remodelling in the liver of rats subjected to dietary choline deprivation and/or thioacetamide administration". Clin Exp Pharmacol Physiol 2018;45:1245-56. [PMID: 30019784 DOI: 10.1111/1440-1681.13013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
698 Peng Y, Yang T, Huang K, Shen L, Tao Y, Liu C. Salvia Miltiorrhiza Ameliorates Liver Fibrosis by Activating Hepatic Natural Killer Cells in Vivo and in Vitro. Front Pharmacol 2018;9:762. [PMID: 30061833 DOI: 10.3389/fphar.2018.00762] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
699 Han X, Hong Y, Zhang K. TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b. Biochem Biophys Res Commun 2018;503:1394-400. [PMID: 30017186 DOI: 10.1016/j.bbrc.2018.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
700 Huang SC, Wang PW, Kuo PC, Hung HY, Pan TL. Hepatoprotective Principles and Other Chemical Constituents from the Mycelium of Phellinus linteus. Molecules 2018;23:E1705. [PMID: 30002357 DOI: 10.3390/molecules23071705] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
701 Du Y, Li N, Long M. Liver sinusoid on a chip. Methods Cell Biol 2018;146:105-34. [PMID: 30037457 DOI: 10.1016/bs.mcb.2018.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
702 Khawar IA, Park JK, Jung ES, Lee MA, Chang S, Kuh HJ. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma. Neoplasia. 2018;20:800-812. [PMID: 29981501 DOI: 10.1016/j.neo.2018.05.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 12.6] [Reference Citation Analysis]
703 Coll M, Perea L, Boon R, Leite SB, Vallverdú J, Mannaerts I, Smout A, El Taghdouini A, Blaya D, Rodrigo-Torres D, Graupera I, Aguilar-Bravo B, Chesne C, Najimi M, Sokal E, Lozano JJ, van Grunsven LA, Verfaillie CM, Sancho-Bru P. Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. Cell Stem Cell 2018;23:101-113.e7. [PMID: 30049452 DOI: 10.1016/j.stem.2018.05.027] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 23.2] [Reference Citation Analysis]
704 Huang YH, Yang YL, Wang FS. The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis. Int J Mol Sci 2018;19:E1889. [PMID: 29954104 DOI: 10.3390/ijms19071889] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
705 Bakr Abdu S, Motlag Al- F. Portal Fibroblast Role in Liver Fibrosis in Rats. International J of Pharmacology 2018;14:717-726. [DOI: 10.3923/ijp.2018.717.726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
706 Oishi Y, Manabe I. Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease. Front Cardiovasc Med 2018;5:69. [PMID: 29942807 DOI: 10.3389/fcvm.2018.00069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
707 Shafigullina AK, Mijanovic O, Prottoy RA, Zhuravleva MN, Gomzikova MO, Gumerova AA, Rizvanov AA, Kiyasov AP. Effect of Curcumin and Gliotoxin on Rat Liver Myofibroblast Culture. BioNanoSci 2018;8:522-536. [DOI: 10.1007/s12668-017-0494-z] [Reference Citation Analysis]
708 Guo X, Cen Y, Wang J, Jiang H. CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway. Biomed Pharmacother. 2018;105:282-289. [PMID: 29860220 DOI: 10.1016/j.biopha.2018.05.128] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
709 Weaver L, Hamoud AR, Stec DE, Hinds TD Jr. Biliverdin reductase and bilirubin in hepatic disease. Am J Physiol Gastrointest Liver Physiol 2018;314:G668-76. [PMID: 29494209 DOI: 10.1152/ajpgi.00026.2018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
710 Bennett RG. Targeting the Relaxin Pathway for Liver Disease Treatment. EMJ Hepatol 2018. [DOI: 10.33590/emjhepatol/10311638] [Reference Citation Analysis]
711 Yang Q, Yan C, Gong Z. Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish. Sci Rep 2018;8:8495. [PMID: 29855567 DOI: 10.1038/s41598-018-26612-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
712 Pan XY, Yang Y, Meng HW, Li HD, Chen X, Huang HM, Bu FT, Yu HX, Wang Q, Huang C, Meng XM, Li J. DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis. Front Pharmacol 2018;9:553. [PMID: 29892223 DOI: 10.3389/fphar.2018.00553] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
713 Ma X, Luo Q, Zhu H, Liu X, Dong Z, Zhang K, Zou Y, Wu J, Ge J, Sun A. Aldehyde dehydrogenase 2 activation ameliorates CCl4 -induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway. J Cell Mol Med 2018. [PMID: 29799157 DOI: 10.1111/jcmm.13677] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
714 Bona S, Rodrigues G, Moreira AJ, Di Naso FC, Dias AS, Da Silveira TR, Marroni CA, Marroni NP. Antifibrogenic effect of melatonin in rats with experimental liver cirrhosis induced by carbon tetrachloride. JGH Open 2018;2:117-23. [PMID: 30483575 DOI: 10.1002/jgh3.12055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
715 Zheng J, Yu F, Dong P, Wu L, Zhang Y, Hu Y, Zheng L. Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152. Oncotarget 2016;7:62886-97. [PMID: 27588491 DOI: 10.18632/oncotarget.11709] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 12.6] [Reference Citation Analysis]
716 Kim BM, Abdelfattah AM, Vasan R, Fuchs BC, Choi MY. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. Sci Rep 2018;8:7499. [PMID: 29760499 DOI: 10.1038/s41598-018-25699-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
717 Qiao H, Zhou Y, Qin X, Cheng J, He Y, Jiang Y. NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation. Stem Cells Int 2018;2018:1239143. [PMID: 29861737 DOI: 10.1155/2018/1239143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
718 Hintermann E, Bayer M, Conti CB, Fuchs S, Fausther M, Leung PS, Aurrand-Lions M, Taubert R, Pfeilschifter JM, Friedrich-Rust M, Schuppan D, Dranoff JA, Gershwin ME, Manns MP, Imhof BA, Christen U. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice. J Autoimmun 2018;91:83-96. [PMID: 29753567 DOI: 10.1016/j.jaut.2018.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
719 Davidson MD, Kukla DA, Khetani SR. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development. Integr Biol (Camb) 2017;9:662-77. [PMID: 28702667 DOI: 10.1039/c7ib00027h] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
720 Pittala S, Krelin Y, Shoshan-Barmatz V. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide. Neoplasia 2018;20:594-609. [PMID: 29747160 DOI: 10.1016/j.neo.2018.02.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
721 You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, Yuan Y, Yang J, Zhuang SM. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. Mol Ther Nucleic Acids. 2018;12:57-66. [PMID: 30195793 DOI: 10.1016/j.omtn.2018.04.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
722 Zhang Y, Miao H, Yan H, Sheng Y, Ji L. Hepatoprotective effect of Forsythiae Fructus water extract against carbon tetrachloride-induced liver fibrosis in mice. Journal of Ethnopharmacology 2018;218:27-34. [DOI: 10.1016/j.jep.2018.02.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
723 Wei G, Wang J, Lv Q, Liu M, Xu H, Zhang H, Jin L, Yu J, Wang X. Three-dimensional coculture of primary hepatocytes and stellate cells in silk scaffold improves hepatic morphology and functionality in vitro. J Biomed Mater Res A 2018;106:2171-80. [PMID: 29607608 DOI: 10.1002/jbm.a.36421] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
724 Marques NC, Mo Reira PRR, Bertolo PHL, Gava FN, Vasconcelos RO. Immunodetection of hepatic stellate cells in dogs with visceral leishmaniasis. Parasitol Res 2018;117:1829-37. [PMID: 29704121 DOI: 10.1007/s00436-018-5870-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
725 El-Lakkany NM, El-Maadawy WH, Seif El-Din SH, Saleh S, Safar MM, Ezzat SM, Mohamed SH, Botros SS, Demerdash Z, Hammam OA. Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study. J Tradit Complement Med 2019;9:45-53. [PMID: 30671365 DOI: 10.1016/j.jtcme.2018.01.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
726 Zeng Z, Wu Y, Cao Y, Yuan Z, Zhang Y, Zhang DY, Hasegawa D, Friedman SL, Guo J. Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cells. Life Sci 2018;203:39-47. [PMID: 29660433 DOI: 10.1016/j.lfs.2018.04.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
727 Sui G, Cheng G, Yuan J, Hou X, Kong X, Niu H. Interleukin (IL)-13, Prostaglandin E2 (PGE2), and Prostacyclin 2 (PGI2) Activate Hepatic Stellate Cells via Protein kinase C (PKC) Pathway in Hepatic Fibrosis. Med Sci Monit. 2018;24:2134-2141. [PMID: 29633755 DOI: 10.12659/msm.906442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
728 Friedman A, Siewe N. Chronic hepatitis B virus and liver fibrosis: A mathematical model. PLoS One 2018;13:e0195037. [PMID: 29634771 DOI: 10.1371/journal.pone.0195037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
729 Keirsse J, Van Damme H, Geeraerts X, Beschin A, Raes G, Van Ginderachter JA. The role of hepatic macrophages in liver metastasis. Cell Immunol 2018;330:202-15. [PMID: 29661474 DOI: 10.1016/j.cellimm.2018.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
730 Su Q, Kumar V, Sud N, Mahato RI. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Adv Drug Deliv Rev 2018;129:54-63. [PMID: 29391222 DOI: 10.1016/j.addr.2018.01.009] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 13.6] [Reference Citation Analysis]
731 Chen C, Soto-Gutierrez A, Baptista PM, Spee B. Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells. Gastroenterology 2018;154:1258-72. [PMID: 29428334 DOI: 10.1053/j.gastro.2018.01.066] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 11.6] [Reference Citation Analysis]
732 Utoh R, Komori J, Kuge H, Tatsumi K, Yamada M, Hirohashi S, Tsutsumi M, Amanuma T, Yoshioka A, Nakajima Y, Wake K, Okano T, Lagasse E, Ohashi K. Adult hepatocytes direct liver organogenesis through non-parenchymal cell recruitment in the kidney. J Hepatol 2018;68:744-53. [PMID: 29288124 DOI: 10.1016/j.jhep.2017.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
733 Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Cellular prognostic markers in hepatitis-related hepatocellular carcinoma. Infect Agent Cancer 2018;13:10. [PMID: 29599818 DOI: 10.1186/s13027-018-0183-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
734 He X, Xie J, Wang Y, Fan X, Su Q, Sun Y, Lei N, Zhang D, Gao G, Pan W. Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. PLoS Pathog 2018;14:e1006957. [PMID: 29554131 DOI: 10.1371/journal.ppat.1006957] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
735 Crespo Yanguas S, da Silva TC, Pereira IVA, Willebrords J, Maes M, Sayuri Nogueira M, Alves de Castro I, Leclercq I, Romualdo GR, Barbisan LF, Leybaert L, Cogliati B, Vinken M. TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice. Int J Mol Sci 2018;19:E817. [PMID: 29534516 DOI: 10.3390/ijms19030817] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
736 Amer J, Salhab A, Doron S, Morali G, Safadi R. A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation. Cytometry A. 2018;93:427-435. [PMID: 29517852 DOI: 10.1002/cyto.a.23202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
737 Carson JP, Ramm GA, Robinson MW, McManus DP, Gobert GN. Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells. Trends Parasitol 2018;34:524-40. [PMID: 29526403 DOI: 10.1016/j.pt.2018.02.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
738 de Oliveira da Silva B, Alberici LC, Ramos LF, Silva CM, da Silveira MB, Dechant CRP, Friedman SL, Sakane KK, Gonçalves LR, Moraes KCM. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1-7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism. Int J Biochem Cell Biol 2018;98:137-55. [PMID: 29524604 DOI: 10.1016/j.biocel.2018.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
739 Baffy G. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2018;63:563-76. [PMID: 29368124 DOI: 10.1007/s10620-017-4903-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
740 Kim KM, Han CY, Kim JY, Cho SS, Kim YS, Koo JH, Lee JM, Lim SC, Kang KW, Kim JS, Hwang SJ, Ki SH, Kim SG. Gα(12) overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol 2018;68:493-504. [PMID: 29080810 DOI: 10.1016/j.jhep.2017.10.011] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 11.6] [Reference Citation Analysis]
741 Artlett CM. The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis? Immunology Letters 2018;195:30-7. [DOI: 10.1016/j.imlet.2017.11.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
742 Li H, Lan J, Han C, Guo K, Wang G, Hu J, Gong J, Luo X, Cao Z. Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Experimental Cell Research 2018;364:191-7. [DOI: 10.1016/j.yexcr.2018.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
743 Karimi-sales E, Mohaddes G, Alipour MR. Chalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms. Pharmacological Research 2018;129:177-87. [DOI: 10.1016/j.phrs.2017.11.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
744 Brandon-Warner E, Benbow JH, Swet JH, Feilen NA, Culberson CR, McKillop IH, deLemos AS, Russo MW, Schrum LW. Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis. Hum Gene Ther 2018;29:674-86. [PMID: 29281894 DOI: 10.1089/hum.2017.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
745 Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructural characteristics of the respective forms of hepatic stellate cells in chronic hepatitis B as an example of high fibroblastic cell plasticity. The first assessment in children. Adv Med Sci 2018;63:127-33. [PMID: 29120853 DOI: 10.1016/j.advms.2017.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
746 Riordan JD, Feddersen CR, Tschida BR, Beckmann PJ, Keng VW, Linden MA, Amin K, Stipp CS, Largaespada DA, Dupuy AJ. Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice. Hepatology 2018;67:924-39. [PMID: 28961327 DOI: 10.1002/hep.29565] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
747 Isfoss BL, Holmqvist B, Sand E, Forsell J, Jernström H, Olsson H. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study. BMC Cancer 2018;18:230. [PMID: 29486751 DOI: 10.1186/s12885-018-4151-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
748 Senoo T, Sasaki R, Akazawa Y, Ichikawa T, Miuma S, Miyaaki H, Taura N, Nakao K. Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice. BMC Gastroenterol 2018;18:34. [PMID: 29486718 DOI: 10.1186/s12876-018-0761-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
749 Wang XY, Gao H, Xie XJ, Jurhiin J, Zhang MZ, Zhou YP, Liu R, Ning M, Han J, Tang HF. Triterpenoid Saponins from Anemone rivularis var. Flore-Minore and Their Anti-Proliferative Activity on HSC-T6 Cells. Molecules 2018;23:E491. [PMID: 29473864 DOI: 10.3390/molecules23020491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
750 You Y, Tan JX, Dai HS, Chen HW, Xu XJ, Yang AG, Zhang YJ, Bai LH, Bie P. MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma. Oncotarget. 2016;7:57099-57116. [PMID: 27494859 DOI: 10.18632/oncotarget.10981] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
751 Eraky SM, El-Mesery M, El-Karef A, Eissa LA, El-Gayar AM. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed Pharmacother 2018;101:49-57. [PMID: 29477472 DOI: 10.1016/j.biopha.2018.02.064] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
752 Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8:3895-3932. [PMID: 27965466 DOI: 10.18632/oncotarget.13904] [Cited by in Crossref: 92] [